<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Remote ischaemic conditioning for preventing and treating ischaemic stroke - Zhao, W - 2018 | Cochrane Library</title> <meta content="Remote ischaemic conditioning for preventing and treating ischaemic stroke - Zhao, W - 2018 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012503.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Remote ischaemic conditioning for preventing and treating ischaemic stroke - Zhao, W - 2018 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012503.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD012503.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Remote ischaemic conditioning for preventing and treating ischaemic stroke" name="citation_title"/> <meta content="Wenbo Zhao" name="citation_author"/> <meta content="Xuanwu Hospital, Capital Medical University" name="citation_author_institution"/> <meta content="Jing Zhang" name="citation_author"/> <meta content="Xuanwu Hospital, Capital Medical University" name="citation_author_institution"/> <meta content="Mordechai G Sadowsky" name="citation_author"/> <meta content="Wayne State University School of Medicine" name="citation_author_institution"/> <meta content="Ran Meng" name="citation_author"/> <meta content="Xuanwu Hospital, Capital Medical University" name="citation_author_institution"/> <meta content="Yuchuan Ding" name="citation_author"/> <meta content="Wayne State University School of Medicine" name="citation_author_institution"/> <meta content="Xunming Ji" name="citation_author"/> <meta content="Xuanwu Hospital, Capital Medical University" name="citation_author_institution"/> <meta content="jixm@ccmu.edu.cn" name="citation_author_email"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="7" name="citation_issue"/> <meta content="10.1002/14651858.CD012503.pub2" name="citation_doi"/> <meta content="2018" name="citation_date"/> <meta content="2018/07/05" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012503.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012503.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012503.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Neuroprotection; Bias; Cerebral Arterial Diseases [complications]; Extremities [blood supply]; Ischemic Preconditioning [*methods, mortality]; Randomized Controlled Trials as Topic; Stroke [mortality, prevention &amp; control, *therapy]; Thrombolytic Therapy [mortality]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012503.pub2&amp;doi=10.1002/14651858.CD012503.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012503.pub2&amp;doi=10.1002/14651858.CD012503.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012503.pub2&amp;doi=10.1002/14651858.CD012503.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012503.pub2&amp;doi=10.1002/14651858.CD012503.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012503.pub2&amp;doi=10.1002/14651858.CD012503.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012503.pub2&amp;doi=10.1002/14651858.CD012503.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012503.pub2&amp;doi=10.1002/14651858.CD012503.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012503.pub2&amp;doi=10.1002/14651858.CD012503.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012503.pub2&amp;doi=10.1002/14651858.CD012503.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012503.pub2&amp;doi=10.1002/14651858.CD012503.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012503.pub2&amp;doi=10.1002/14651858.CD012503.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012503.pub2&amp;doi=10.1002/14651858.CD012503.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012503.pub2&amp;doi=10.1002/14651858.CD012503.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012503.pub2&amp;doi=10.1002/14651858.CD012503.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012503.pub2&amp;doi=10.1002/14651858.CD012503.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012503.pub2&amp;doi=10.1002/14651858.CD012503.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012503.pub2&amp;doi=10.1002/14651858.CD012503.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012503.pub2&amp;doi=10.1002/14651858.CD012503.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012503.pub2&amp;doi=10.1002/14651858.CD012503.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012503.pub2&amp;doi=10.1002/14651858.CD012503.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012503.pub2&amp;doi=10.1002/14651858.CD012503.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012503.pub2&amp;doi=10.1002/14651858.CD012503.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012503.pub2&amp;doi=10.1002/14651858.CD012503.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="KUoIaN9D";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD012503\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD012503\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012503\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012503\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ru","pt","fa","fr","ms","zh_HANS"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD012503.pub2",title:"Remote ischaemic conditioning for preventing and treating ischaemic stroke",firstPublishedDate:"Jul 5, 2018 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Stroke Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=KUoIaN9D&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012503.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012503.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD012503.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD012503.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012503.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD012503.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012503.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD012503.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012503.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD012503.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo para leigos&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD012503.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD012503.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD012503.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD012503.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>3077 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD012503.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012503.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012503.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012503.pub2/full#CD012503-abs-0006"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012503.pub2/full#CD012503-sec-0118"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012503.pub2/full#CD012503-sec-0036"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012503.pub2/full#CD012503-sec-0037"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012503.pub2/full#CD012503-sec-0042"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012503.pub2/full#CD012503-sec-0043"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012503.pub2/full#CD012503-sec-0067"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012503.pub2/full#CD012503-sec-0110"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD012503.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012503.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012503.pub2/appendices#CD012503-sec-0123"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012503.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012503.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD012503.pub2/media/CDSR/CD012503/table_n/CD012503StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD012503.pub2/media/CDSR/CD012503/table_n/CD012503StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012503.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012503.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012503.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD012503.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD012503.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD012503.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2019 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD012503.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Remote ischaemic conditioning for preventing and treating ischaemic stroke</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012503.pub2/information#CD012503-cr-0002">Wenbo Zhao</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012503.pub2/information#CD012503-cr-0003">Jing Zhang</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012503.pub2/information#CD012503-cr-0004">Mordechai G Sadowsky</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012503.pub2/information#CD012503-cr-0005">Ran Meng</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012503.pub2/information#CD012503-cr-0006">Yuchuan Ding</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012503.pub2/information#CD012503-cr-0007"><i class="icon corresponding-author fa fa-envelope"></i>Xunming Ji</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD012503.pub2/information/en#CD012503-sec-0137">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 05 July 2018 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD012503.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD012503.pub2">https://doi.org/10.1002/14651858.CD012503.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD012503-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012503-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012503-abs-0005">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012503-abs-0003">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD012503-abs-0004">Français</a> </li> <li class="section-language"> <a class="" href="full/pt#CD012503-abs-0002">Português</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD012503-abs-0013">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD012503-abs-0001" lang="en"> <section id="CD012503-sec-0001"> <h3 class="title" id="CD012503-sec-0001">Background</h3> <p>Remote ischaemic conditioning (RIC) has been developed as a neuroprotective strategy to prevent and treat ischaemic stroke. It usually involves restricting blood flow to limbs and then releasing the ischaemic blood to promote a neuroprotective effect. Preclinical studies have suggested that RIC may have beneficial effects in ischaemic stroke patients and those at risk of ischaemic stroke. However, existing evidence is insufficient to demonstrate the efficacy and safety of RIC in preventing and treating ischaemic stroke. </p> </section> <section id="CD012503-sec-0002"> <h3 class="title" id="CD012503-sec-0002">Objectives</h3> <p>To assess the benefits and harms of RIC for preventing ischaemic stroke and for treating people with ischaemic stroke and those at risk for ischaemic stroke. </p> </section> <section id="CD012503-sec-0003"> <h3 class="title" id="CD012503-sec-0003">Search methods</h3> <p>We searched the Cochrane Stroke Group Trials Register (16 January 2018), the Cochrane Central Register of Controlled Trials (CENTRAL; 2017, Issue 12) in the <i>Cochrane Library</i> (January 2018), MEDLINE Ovid (1946 to January 2018), Embase Ovid (1974 to January 2018), Web of Science Core Collection (1950 to January 2018) and three Chinese databases (January 2018). We also searched four ongoing trials registers, reference lists, and conference proceedings. </p> </section> <section id="CD012503-sec-0004"> <h3 class="title" id="CD012503-sec-0004">Selection criteria</h3> <p>We included randomised controlled trials (RCTs) comparing RIC with sham RIC or medical management in people with ischaemic stroke or at risk of ischaemic stroke. </p> </section> <section id="CD012503-sec-0005"> <h3 class="title" id="CD012503-sec-0005">Data collection and analysis</h3> <p>Two review authors independently selected studies, assessed trial quality and risk of bias, and extracted data. We used the GRADE approach to assess the quality of the evidence. </p> </section> <section id="CD012503-sec-0006"> <h3 class="title" id="CD012503-sec-0006">Main results</h3> <p>We included seven trials, involving 735 participants, in this review. We analysed the effects of RIC on preventing and treating ischaemic stroke respectively. </p> <p>We evaluated risk of bias and judged it to be low for generation of allocation sequence in six studies and unclear in one study; unclear for allocation concealment in four studies and low in three studies; high for incomplete outcome data (attrition bias) in five studies and low in two studies; high for blinding in three studies and low in four studies; low for selective reporting; and high for other sources of bias in six studies and low in one study. </p> <p>We included three trials (involving 371 participants) in the analysis of the effects of RIC on ischaemic stroke prevention. In people with symptomatic intracerebral artery stenosis, recurrent stroke was significantly reduced by RIC (risk ratio (RR) 0.32, 95% confidence interval (CI) 0.12 to 0.83; 2 trials, 182 participants, low‐quality evidence). In people with carotid stenosis undergoing carotid stenting, there was no significant difference in the incidence of ischaemic stroke between participants treated with RIC and non‐RIC (RR 0.22, 95% CI 0.01 to 4.03; 1 trial, 189 participants, low‐quality evidence); however the stroke severity (assessed by infarct volume) was significantly lower in participants treated with RIC (mean difference (MD) ‐0.17 mL, 95% CI ‐0.23 to ‐0.11; 1 trial, 189 participants, low‐quality evidence). Adverse events associated with RIC were significantly higher in participants treated with RIC (RR 10.91; 95% CI 2.01 to 59.28; 3 trials, 371 participants, low‐quality evidence), but no severe adverse event was attributable to RIC treatment. No participants experienced death or cardiovascular events during the period of the studies; and no trial reported haemorrhagic stroke or improvement in neurological, phycological or cognitive impairment. </p> <p>We included four trials (involving 364 participants) in the analysis of the effects of RIC on ischaemic stroke treatment. In acute ischaemic stroke, for people receiving intravenous thrombolysis, the rate of death or dependency was significantly increased by RIC treatment compared with non‐RIC treatment (RR 2.34; 95% 1.19 to 4.61; 1 trial, 285 participants, low‐quality evidence). In people with acute ischaemic stroke, there was no significant difference between RIC and non‐RIC for reducing stroke severity as assessed by the National Institutes of Health Stroke Scale score and the final infarct volume (standardised mean difference (SMD) ‐0.24 mL, 95% CI ‐1.02 to 0.54; 2 trials, 175 participants, very low quality evidence). There was no significant difference between RIC and non‐RIC for improving the psychological impairment (SMD ‐0.37 points, 95% CI ‐1.15 to 0.41; 1 trial, 26 participants, very low quality evidence) and the cognitive impairment (SMD ‐0.26 points; 95% CI ‐0.72 to 0.21; 3 trials, 79 participants, low‐quality evidence) in people with acute ischaemic stroke and cerebral small vessel disease. No trial reported ischaemic stroke, recurrent ischaemic stroke, improvement in neurological impairment, hemorrhagic stroke, cardiovascular events, and RIC associated adverse events. </p> </section> <section id="CD012503-sec-0007"> <h3 class="title" id="CD012503-sec-0007">Authors' conclusions</h3> <p>We found low‐quality evidence that RIC may reduce the risk of recurrent stroke in participants with intracerebral artery stenosis and reduce stroke severity in participants undergoing carotid stenting, but it may increase death or dependence in participants with acute ischaemic stroke who are undergoing intravenous thrombolysis. However, there is considerable uncertainty about these conclusions because of the small number of studies and low quality of the evidence. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD012503-abs-0006" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012503-abs-0006">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012503-abs-0011">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012503-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD012503-abs-0010">Français</a> </li> <li class="section-language"> <a class="" href="full/ms#CD012503-abs-0012">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pt#CD012503-abs-0008">Português</a> </li> <li class="section-language"> <a class="" href="full/ru#CD012503-abs-0007">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD012503-abs-0014">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD012503-abs-0006" lang="en"> <h3>Remote ischaemic conditioning for preventing and treating stroke caused by low blood flow </h3> <p><b>Review question</b> </p> <p>What are the benefits of using remote ischaemic conditioning (a noninvasive physical therapy that involves inflating blood pressure cuffs to reduce blood flow in arms and legs, and then releasing the affected blood around the body) in people with stroke or those at risk of stroke caused by low blood flow? </p> <p><b>Background</b> </p> <p>Stroke is the leading cause of adult disability globally, and ischaemic stroke (caused by reduced blood flow) accounts for most strokes. Nearly a quarter of individuals with ischaemic stroke will experience further events (recurrent stroke). Remote ischaemic conditioning (RIC) is a strategy to protect and prevent damage to brain tissue by improving its ability to tolerate reduced blood flow. Studies have suggested that RIC may have beneficial effects for preventing and treating ischaemic stroke. </p> <p><b>Study characteristics</b> </p> <p>This review included seven studies (specifically randomised controlled trials), involving 735 people. The studies compared RIC with sham RIC or medical management in people with ischaemic stroke or at risk of ischaemic stroke. Three trials (involving 371 people) were eligible for our analysis of RIC for preventing ischaemic stroke, and another four trials (involving 364 people) were eligible for our analysis of RIC for treating ischaemic stroke. The included trials were carried out in China, Denmark, and the UK. </p> <p><b>Key results</b> </p> <p>The results of this review are current up to January 2018. In people with narrowing of arteries in the brain, RIC may reduce the risk of recurrent stroke. In people being treated with stenting (the insertion of a metal or plastic tube) for narrowed arteries in the neck, RIC may reduce the size of new brain injuries caused by reduced blood flow. However, its effect on clinical outcomes (stroke and death) was unclear. Adverse events were significantly more common in the RIC group but were not reported to be severe. </p> <p>Among people with acute ischaemic stroke (where it had only been several hours from symptom onset) who received clot‐dissolving medicines, we found that RIC may increase the risk of death or dependency (needing help from others). We found no significant differences in the size of the final stroke. In people with acute ischaemic stroke and chronic blood vessel disease of the brain, RIC did not affect measures of nerve function, mood, or thinking ability. </p> <p><b>Quality of evidence</b> </p> <p>There is low‐quality evidence which suggests that RIC may help prevent recurrent stroke in people with narrowed arteries in the brain, and may increase death or dependency in people with acute ischaemic stroke who received clot dissolving medication. The evidence is less clear for reducing the volume of the stroke (size of brain lesion caused by low blood flow). Further research is likely to have an important impact on our confidence in these findings. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD012503-sec-0118" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD012503-sec-0118"></div> <h3 class="title" id="CD012503-sec-0119">Implications for practice</h3> <section id="CD012503-sec-0119"> <p>We found low‐quality evidence that remote ischaemic conditioning (RIC) may reduce the risk of recurrent stroke in participants with intracerebral artery stenosis, reduce infarct volume in participants undergoing carotid stenting, and increase dependence or death in participants with acute ischaemic stroke who are undergoing intravenous thrombolysis. However, based on the current low‐quality evidence from several small trials, it is difficult to determine whether people with symptomatic intracerebral artery stenosis, acute ischaemic stroke, cerebral small vessel disease, or those undergoing carotid artery stenting will benefit from RIC. Routine use of RIC to prevent or treat ischaemic stroke cannot be supported by the current evidence. Although adverse events were more common with RIC caused by cuff inflation, serious adverse events were not reported. </p> </section> <h3 class="title" id="CD012503-sec-0120">Implications for research</h3> <section id="CD012503-sec-0120"> <p>Further large‐scale trials may be worthwhile to determine the efficacy of RIC in treating acute ischaemic stroke, especially those treated with reperfusion therapy (e.g. intravenous thrombolysis and endovascular therapy). Researchers are also encouraged to investigate RIC in other subtypes of cerebrovascular diseases (e.g. haemorrhagic stroke). Furthermore, the optimal dose and the treatment protocol for RIC treatment needs further investigation. The safety of RIC needs to be further determined in adequately‐designed studies, and further studies should be conducted and reported according to the CONSORT Statement (<a href="./references#CD012503-bbs2-0052" title="SchulzKF , AltmanDG , MoherD . CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ2010;340:c332. ">Schulz 2010</a>). </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD012503-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD012503-sec-0036"></div> <div class="table" id="CD012503-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">RIC versus non‐RIC for preventing ischaemic stroke</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>RIC versus non‐RIC for preventing ischaemic stroke</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people at risk for ischaemic stroke<br/> <b>Setting:</b> clinic and inpatient<br/> <b>Intervention:</b> RIC<br/> <b>Comparison:</b> non‐RIC </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with non‐RIC for preventing ischaemic stroke</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with RIC</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Ischaemic stroke or recurrent ischaemic stroke</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Symptomatic intracerebral artery stenosis or carotid stenting</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.31<br/> (0.12 to 0.76) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>371<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>92 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>29 per 1000<br/> (11 to 70) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Death or dependency</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Symptomatic intracerebral artery stenosis or carotid stenting</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>292<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000<br/> (0 to 0) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Improvement in neurological impairment ‐ not reported</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Improvement in psychological and cognitive impairment ‐ not measured</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cardiovascular events ‐ not reported</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Adverse events associated with RIC treatment</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Symptomatic intracerebral artery stenosis or carotid stenting</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 10.91<br/> (2.01 to 59.28) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>371<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000<br/> (0 to 0) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Stroke severity</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.17 lower<br/> (0.23 lower to 0.11 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>189<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>4 5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio; <b>RIC:</b> remote ischaemic conditioning; <b>RCT:</b> randomised controlled trial; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgrade by two levels because of very serious risk of bias and serious imprecision. Very serious risk of bias resulted from: participants were not blinded to the treatment protocol in <a href="./references#CD012503-bbs2-0003" title="MengR , AsmaroK , MengL , LiuY , MaC , XiC , et al. Upper limb ischemic preconditioning prevents recurrent stroke in intracranial arterial stenosis. Neurology2012;79(18):1853‐61. [PUBMED: PMID: 23035060] ">Meng 2012</a> and <a href="./references#CD012503-bbs2-0007" title="ZhaoW , MengR , MaC , HouB , JiaoL , ZhuF , et al. Safety and efficacy of remote ischemic preconditioning in patients with severe carotid artery stenosis before carotid artery stenting: a proof‐of‐concept, randomized controlled trial. Circulation2017;135(14):1325‐35. [PUBMED: PMID: 28174194] ">Zhao 2017</a>; <a href="./references#CD012503-bbs2-0003" title="MengR , AsmaroK , MengL , LiuY , MaC , XiC , et al. Upper limb ischemic preconditioning prevents recurrent stroke in intracranial arterial stenosis. Neurology2012;79(18):1853‐61. [PUBMED: PMID: 23035060] ">Meng 2012</a> and <a href="./references#CD012503-bbs2-0004" title="MengR , DingY , AsmaroK , BroganD , MengL , SuiM , et al. Ischemic conditioning is safe and effective for octo‐ and nonagenarians in stroke prevention and treatment. Neurotherapeutics2015;12(3):667‐77. [PUBMED: PMID: 25956401] ">Meng 2015</a> used per‐protocol analysis methods; the corresponding author was one of the inventor of the RIC devices used in the studies; and there was large number of participants lost to follow up during the study period. </p> <p><sup>2</sup> Serious imprecision. Incidence of ischaemic stroke was very lower in <a href="./references#CD012503-bbs2-0007" title="ZhaoW , MengR , MaC , HouB , JiaoL , ZhuF , et al. Safety and efficacy of remote ischemic preconditioning in patients with severe carotid artery stenosis before carotid artery stenting: a proof‐of‐concept, randomized controlled trial. Circulation2017;135(14):1325‐35. [PUBMED: PMID: 28174194] ">Zhao 2017</a>, and the CI for ischaemic stroke was wide. </p> <p><sup>3</sup> Serious imprecision. Incidence of RIC‐associated adverse events were very lower, and the CI for this outcome was very wide. </p> <p><sup>4</sup> Downgrade by two levels because of serious risk of bias and serious indirectness. Very serious risk of bias results from: participants were not blinded to the treatment protocol; the corresponding author was one of the inventor of the RIC devices used; and there was large number of participants lost to follow up during the study period in <a href="./references#CD012503-bbs2-0007" title="ZhaoW , MengR , MaC , HouB , JiaoL , ZhuF , et al. Safety and efficacy of remote ischemic preconditioning in patients with severe carotid artery stenosis before carotid artery stenting: a proof‐of‐concept, randomized controlled trial. Circulation2017;135(14):1325‐35. [PUBMED: PMID: 28174194] ">Zhao 2017</a>. </p> <p><sup>5</sup> Serious indirectness. The infarct volume was used as a surrogate endpoint to assess stroke severity in <a href="./references#CD012503-bbs2-0007" title="ZhaoW , MengR , MaC , HouB , JiaoL , ZhuF , et al. Safety and efficacy of remote ischemic preconditioning in patients with severe carotid artery stenosis before carotid artery stenting: a proof‐of‐concept, randomized controlled trial. Circulation2017;135(14):1325‐35. [PUBMED: PMID: 28174194] ">Zhao 2017</a>. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD012503-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">RIC versus non‐RIC treating ischaemic stroke</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>RIC versus non‐RIC for treating ischaemic stroke</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with ischaemic stroke<br/> <b>Setting:</b> emergency, clinic and inpatient<br/> <b>Intervention:</b> RIC<br/> <b>Comparison:</b> non‐RIC </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with non‐RIC treating ischaemic stroke</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with RIC</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ischaemic stroke or recurrent ischaemic stroke at completion of follow‐up ‐ not measured</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Death or dependency</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Acute ischaemic stroke treated with intravenous thrombolysis</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 2.34<br/> (1.19 to 4.61) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>285<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>80 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>187 per 1000<br/> (95 to 369) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Improvement in neurological impairment ‐ not measured</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Improvement in psychological and cognitive impairment at completion of follow‐up</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean psychological function was 55.4 points and the mean cognitive function was 27.08 points. </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>SMD 0.29 lower<br/> (0.68 lower to 0.11 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>105<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>3 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cardiovascular events ‐ not reported</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events associated with RIC treatment ‐ not reported</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Stroke severity</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>SMD 0.24 lower<br/> (1.02 lower to 0.54 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>175<br/> (2 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>4 5 6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio; <b>RIC:</b> remote ischaemic conditioning; <b>SMD:</b> standardised mean difference; <b>RCT:</b> randomised controlled trial; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgrade two levels by very serious risk of bias and serious imprecision. High risk of bias resulted from the unclear of allocation concealment, the unblinded treatment protocol to the participants, and large number of participants lost to follow up during the study period in <a href="./references#CD012503-bbs2-0002" title="HougaardKD , HjortN , ZeidlerD , SorensenL , NorgaardA , HansenTM , et al. Remote ischemic perconditioning as an adjunct therapy to thrombolysis in patients with acute ischemic stroke: a randomized trial. Stroke2014;45(159):67. [PUBMED: PMID: 24203849] ">Hougaard 2014</a>. </p> <p><sup>2</sup> Serious imprecision. There was a large number of participants excluded from the study after randomising in <a href="./references#CD012503-bbs2-0002" title="HougaardKD , HjortN , ZeidlerD , SorensenL , NorgaardA , HansenTM , et al. Remote ischemic perconditioning as an adjunct therapy to thrombolysis in patients with acute ischemic stroke: a randomized trial. Stroke2014;45(159):67. [PUBMED: PMID: 24203849] ">Hougaard 2014</a>. </p> <p><sup>3</sup> Downgrade two levels by very serious risk of bias and serious inconsistency. Very serious risk of bias resulted from the unclear of allocation concealment and high risk of other bias in <a href="./references#CD012503-bbs2-0005" title="MiT , YuF , JiX , SunY , QuD . The interventional effect of remote ischemic preconditioning on cerebral small vessel disease: a pilot randomized clinical trial. European Neurology2016;76(1‐2):28‐34. [PUBMED: PMID: 27351719] ">Mi 2016</a> and <a href="./references#CD012503-bbs2-0006" title="WangY , MengR , SongH , LiuG , HuaY , CuiD , et al. Remote ischemic conditioning may improve outcomes of patients with cerebral small‐vessel disease. Stroke2017;48(11):3064‐72. [PUBMED: PMID: 29042490 ] ">Wang 2017</a>, only a small number of participant were included for this outcome, and the corresponding author was one of the inventors of the RIC devices used in <a href="./references#CD012503-bbs2-0005" title="MiT , YuF , JiX , SunY , QuD . The interventional effect of remote ischemic preconditioning on cerebral small vessel disease: a pilot randomized clinical trial. European Neurology2016;76(1‐2):28‐34. [PUBMED: PMID: 27351719] ">Mi 2016</a> and <a href="./references#CD012503-bbs2-0006" title="WangY , MengR , SongH , LiuG , HuaY , CuiD , et al. Remote ischemic conditioning may improve outcomes of patients with cerebral small‐vessel disease. Stroke2017;48(11):3064‐72. [PUBMED: PMID: 29042490 ] ">Wang 2017</a>. </p> <p><sup>4</sup> Serious inconsistency. We detected high level of the heterogeneity for the cognitive impairment. </p> <p><sup>5</sup> Downgrade two levels by very serious risk of bias, serious inconsistency and serious indirectness. High risk of bias resulted from the unclear of allocation concealment, the unblinded treatment protocol to the participants, and large number of participants lost to follow up during the study period in <a href="./references#CD012503-bbs2-0002" title="HougaardKD , HjortN , ZeidlerD , SorensenL , NorgaardA , HansenTM , et al. Remote ischemic perconditioning as an adjunct therapy to thrombolysis in patients with acute ischemic stroke: a randomized trial. Stroke2014;45(159):67. [PUBMED: PMID: 24203849] ">Hougaard 2014</a>; and the small number of participants in <a href="./references#CD012503-bbs2-0001" title="EnglandT , HedstromA , O'SullivanS , DonnellyR , SpriggN , BathP . Remote ischaemic conditioning after stroke trial (RECAST). International Journal of Stroke2016;11 Suppl 4:6. ">England 2016</a>. </p> <p><sup>6</sup> Serious indirectness. The infarct volume was used as a surrogate endpoint to assess stroke severity in <a href="./references#CD012503-bbs2-0002" title="HougaardKD , HjortN , ZeidlerD , SorensenL , NorgaardA , HansenTM , et al. Remote ischemic perconditioning as an adjunct therapy to thrombolysis in patients with acute ischemic stroke: a randomized trial. Stroke2014;45(159):67. [PUBMED: PMID: 24203849] ">Hougaard 2014</a>. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD012503-sec-0037" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD012503-sec-0037"></div> <section id="CD012503-sec-0038"> <h3 class="title" id="CD012503-sec-0038">Description of the condition</h3> <p>Stroke is the leading cause of adult disability globally, and its disease burden continues to increase (<a href="./references#CD012503-bbs2-0035" title="FeiginVL , KrishnamurthiRV , ParmarP , NorrvingB , MensahGA , BennettDA , et al. Update on the global burden of ischemic and hemorrhagic stroke in 1990‐2013: the GBD 2013 study. Neuroepidemiology2015;45(3):161‐76. ">Feigin 2015</a>; <a href="./references#CD012503-bbs2-0051" title="RothGA , ForouzanfarMH , MoranAE , BarberR , NguyenG , FeiginVL , et al. Demographic and epidemiologic drivers of global cardiovascular mortality. New England Journal of Medicine2015;372(14):1333‐41. ">Roth 2015</a>). Ischaemic stroke, which is due to blockage of a brain blood vessel, accounts for nearly 90% of all strokes; and nearly a quarter of individuals who have an ischaemic stroke will have recurrent strokes (<a href="./references#CD012503-bbs2-0056" title="Writing Group Members, MozaffarianD , BenjaminEJ , GoAS , ArnettDK , BlahaMJ , et al. Heart disease and stroke statistics‐2016 update: a report from the American Heart Association. Circulation2016;133(4):e38‐236. ">Writing Group 2016</a>). In 2013, more than 70% of stroke survivors and more than 50% of deaths from stroke were attributed to ischaemic stroke (<a href="./references#CD012503-bbs2-0035" title="FeiginVL , KrishnamurthiRV , ParmarP , NorrvingB , MensahGA , BennettDA , et al. Update on the global burden of ischemic and hemorrhagic stroke in 1990‐2013: the GBD 2013 study. Neuroepidemiology2015;45(3):161‐76. ">Feigin 2015</a>). </p> <p>Fortunately, most ischaemic strokes are preventable. Prevention and screening of stroke not only reduces the incidence of ischaemic stroke and subsequent disability but may have beneficial effects on cognitive decline and other neuropsychological diseases. Key strategies for preventing ischaemic stroke include control of risk factors, anti‐clotting therapy, intervention for vascular obstruction and lifestyle change (<a href="./references#CD012503-bbs2-0053" title="SteigerN , CifuAS . Primary prevention of stroke. Journal of the American Medical Association2016;316(6):658‐9. ">Steiger 2016</a>). Although these strategies play important roles in clinical practice, some are not cost effective and others may result in severe adverse events. </p> <p>Timely intervention to open the occluded artery and return blood flow to salvageable cerebral tissue via clot‐treating therapies (including systemic and local administration of drugs to break up clots and use of various intra‐arterial minimally‐invasive devices to manually remove clots) are the most effective methods for salvaging brain tissue that had interrupted blood flow but is not already dead. The exact window of time for maximally effective treatment is unknown, but strong evidence shows that systemic administration of a drug to break up clots is only beneficial within 4.5 hours of symptom onset, while minimally‐invasive management with second‐generation mechanical clot‐removal devices is beneficial for patients with specific type of stroke within 24 hours of symptom onset (<a href="./references#CD012503-bbs2-0047" title="PowersWJ , RabinsteinAA , AckersonT , AdeoyeOM , BambakidisNC , BeckerK , et al. 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American StrokeAssociation. Stroke2018;49(3):e46‐e110. ">Powers 2018</a>; <a href="./references#CD012503-bbs2-0045" title="NogueiraRG , JadhavAP , HaussenDC , BonafeA , BudzikRF , BhuvaP , et al. Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct. New England Journal of Medicine2018;378(1):11‐21. ">Nogueira 2018</a>). Unfortunately, these treatments are expensive and are available only at select comprehensive stroke centres. Furthermore, injury to surviving brain tissue after reestablishment of blood flow (a phenomenon known as ischaemia/reperfusion injury) is a major source of morbidity and mortality (<a href="./references#CD012503-bbs2-0032" title="BaiJ , LydenPD . Revisiting cerebral postischemic reperfusion injury: new insights in understanding reperfusion failure, hemorrhage, and edema. International Journal of Stroke2015;10(2):143‐52. ">Bai 2015</a>). These disadvantages severely influence the prognosis of ischaemic stroke worldwide, especially in countries with low to medium levels of resources, such as China. </p> </section> <section id="CD012503-sec-0039"> <h3 class="title" id="CD012503-sec-0039">Description of the intervention</h3> <p>Ischaemic conditioning is a strategy by which one or more cycles of a brief period of interruption of blood flow to an organ or tissue followed by resumption of flow confer protection against subsequent, more severe ischaemic events (<a href="./references#CD012503-bbs2-0038" title="HausenloyDJ , YellonDM . Ischaemic conditioning and reperfusion injury. Nature Reviews Cardiology2016;13(4):193‐209. ">Hausenloy 2016</a>). This far‐reaching phenomenon was first demonstrated by Murry and colleagues (<a href="./references#CD012503-bbs2-0044" title="MurryCE , JenningsRB , ReimerKA . Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation1986;74(5):1124‐36. ">Murry 1986</a>). Since that time, ischaemic conditioning has been widely studied. However, a major disadvantage of attempting to condition a specific organ is that it requires application of an intervention directly to the target, which is not always feasible in clinical practice. A strategy by which the protective conditioning cycles are applied to an organ or tissue remote from the target organs may offer a far more attractive clinical application. Przyklenk and colleagues introduced a new method of carrying out ischaemic conditioning, in which the conditioning cycles of ischaemia were applied to a separate region (<a href="./references#CD012503-bbs2-0048" title="PrzyklenkK , BauerB , OvizeM , KlonerRA , WhittakerP . Regional ischemic 'preconditioning' protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation1993;87(3):893‐9. ">Przyklenk 1993</a>). Later on, this strategy was named 'remote ischaemic conditioning' (RIC). Investigators have evaluated many tissues and organs such as kidney, liver, limbs, and the mesenteric artery as remote conditioning sites in animals. RIC performed on limbs, generally with blood pressure cuffs inflated to a pressure that blocks blood flow in one or both directions, is now considered the most convenient and feasible method that can be used in clinical settings (<a href="./references#CD012503-bbs2-0038" title="HausenloyDJ , YellonDM . Ischaemic conditioning and reperfusion injury. Nature Reviews Cardiology2016;13(4):193‐209. ">Hausenloy 2016</a>; <a href="./references#CD012503-bbs2-0046" title="PanJ , LiX , PengY . Remote ischemic conditioning for acute ischemic stroke: dawn in the darkness. Reviews in the Neurosciences2016;27(5):501‐10. ">Pan 2016</a>). RIC can be divided into three types on the basis of initiation of conditioning: preconditioning (RIC applied before ischaemia), perconditioning (RIC applied after ischaemia onset and before reperfusion), and postconditioning (RIC applied during reperfusion) (<a href="./references#CD012503-bbs2-0046" title="PanJ , LiX , PengY . Remote ischemic conditioning for acute ischemic stroke: dawn in the darkness. Reviews in the Neurosciences2016;27(5):501‐10. ">Pan 2016</a>). </p> <p>Many research studies have shown RIC to be a well tolerated and effective strategy for protecting the brain from ischaemia or reperfusion injury (<a href="./references#CD012503-bbs2-0037" title="HahnCD , ManlhiotC , SchmidtMR , NielsenTT , RedingtonAN . Remote ischemic per‐conditioning: a novel therapy for acute stroke?. Stroke2011;42(10):2960‐2. ">Hahn 2011</a>; <a href="./references#CD012503-bbs2-0041" title="HodaMN , SiddiquiS , HerbergS , Periyasamy‐ThandavanS , BhatiaK , HafezSS , et al. Remote ischemic perconditioning is effective alone and in combination with intravenous tissue‐type plasminogen activator in murine model of embolic stroke. Stroke2012;43(10):2794‐9. ">Hoda 2012</a>; <a href="./references#CD012503-bbs2-0002" title="HougaardKD , HjortN , ZeidlerD , SorensenL , NorgaardA , HansenTM , et al. Remote ischemic perconditioning as an adjunct therapy to thrombolysis in patients with acute ischemic stroke: a randomized trial. Stroke2014;45(159):67. [PUBMED: PMID: 24203849] ">Hougaard 2014</a>; <a href="./references#CD012503-bbs2-0046" title="PanJ , LiX , PengY . Remote ischemic conditioning for acute ischemic stroke: dawn in the darkness. Reviews in the Neurosciences2016;27(5):501‐10. ">Pan 2016</a>; <a href="./references#CD012503-bbs2-0049" title="RenC , WangP , WangB , LiN , LiW , ZhangC , et al. Limb remote ischemic per‐conditioning in combination with post‐conditioning reduces brain damage and promotes neuroglobin expression in the rat brain after ischemic stroke. Restorative Neurology and Neuroscience2015;33(3):369‐79. ">Ren 2015</a>). It has been determined that RIC could increase brain tolerance to injury caused by ischaemia, reduce the risk of cerebral infarction, improve blood flow to the brain, and promote the formation of alternately‐routed blood vessels to the brain (<a href="./references#CD012503-bbs2-0002" title="HougaardKD , HjortN , ZeidlerD , SorensenL , NorgaardA , HansenTM , et al. Remote ischemic perconditioning as an adjunct therapy to thrombolysis in patients with acute ischemic stroke: a randomized trial. Stroke2014;45(159):67. [PUBMED: PMID: 24203849] ">Hougaard 2014</a>; <a href="./references#CD012503-bbs2-0003" title="MengR , AsmaroK , MengL , LiuY , MaC , XiC , et al. Upper limb ischemic preconditioning prevents recurrent stroke in intracranial arterial stenosis. Neurology2012;79(18):1853‐61. [PUBMED: PMID: 23035060] ">Meng 2012</a>; <a href="./references#CD012503-bbs2-0046" title="PanJ , LiX , PengY . Remote ischemic conditioning for acute ischemic stroke: dawn in the darkness. Reviews in the Neurosciences2016;27(5):501‐10. ">Pan 2016</a>). Several randomised controlled trials (RCTs) have reported that RIC might confer neuroprotection against damage from acute ischaemic stroke and chronic cerebral ischaemia (<a href="./references#CD012503-bbs2-0002" title="HougaardKD , HjortN , ZeidlerD , SorensenL , NorgaardA , HansenTM , et al. Remote ischemic perconditioning as an adjunct therapy to thrombolysis in patients with acute ischemic stroke: a randomized trial. Stroke2014;45(159):67. [PUBMED: PMID: 24203849] ">Hougaard 2014</a>; <a href="./references#CD012503-bbs2-0003" title="MengR , AsmaroK , MengL , LiuY , MaC , XiC , et al. Upper limb ischemic preconditioning prevents recurrent stroke in intracranial arterial stenosis. Neurology2012;79(18):1853‐61. [PUBMED: PMID: 23035060] ">Meng 2012</a>; <a href="./references#CD012503-bbs2-0004" title="MengR , DingY , AsmaroK , BroganD , MengL , SuiM , et al. Ischemic conditioning is safe and effective for octo‐ and nonagenarians in stroke prevention and treatment. Neurotherapeutics2015;12(3):667‐77. [PUBMED: PMID: 25956401] ">Meng 2015</a>). Although evidence suggests potential benefit of RIC for people with ischaemic stroke, many questions remain unanswered. The underlying protective mechanisms of RIC still need to be elucidated, and the optimal duration and number of ischaemia/reperfusion cycles have not been established. Additionally, the potential for complications related to pressure cuffs is regarded as low, and other adverse effects associated with RIC remain unknown. Finally, criteria are needed that can be used to identify ideal candidate people for RIC. </p> </section> <section id="CD012503-sec-0040"> <h3 class="title" id="CD012503-sec-0040">How the intervention might work</h3> <p>Characterisation of the mechanism by which RIC provides protection for the brain is currently incomplete, and most evidence has been provided by studies on cardiac preconditioning and postconditioning. Underlying mechanisms include two windows of protection: the early phase (action immediately after a stimulus that might play a role through affecting critical proteins) and the delayed phase (action days or weeks after a stimulus that might play a role in gene regulation and new protein synthesis) (<a href="./references#CD012503-bbs2-0037" title="HahnCD , ManlhiotC , SchmidtMR , NielsenTT , RedingtonAN . Remote ischemic per‐conditioning: a novel therapy for acute stroke?. Stroke2011;42(10):2960‐2. ">Hahn 2011</a>). Research findings indicate that protective signals may be transmitted from the conditioned organ to the brain through three routes: humoral, neuronal, and immunological pathways (<a href="./references#CD012503-bbs2-0055" title="WeberC . Far from the heart: receptor cross‐talk in remote conditioning. Nature Medicine2010;16(7):760‐2. ">Weber 2010</a>). </p> <p>Substances or humoral factors generated by the conditioned site may be circulated to the brain through the blood upon re‐establishment of blood flow of the conditioned site and may exert protective effects through signal pathways. A neuronal pathway at conditioned sites might be stimulated by local production of factors such as adenosine, bradykinin or other neuropeptides, which then stimulate nerve signals to the brain, thus inducing neuroprotection. RIC may derive its protective effects via alteration of gene and small molecule expression within the immune system, which then activates immune cells and alters inflammatory responses (<a href="./references#CD012503-bbs2-0042" title="LimSY , HausenloyDJ . Remote ischemic conditioning: from bench to bedside. Frontiers in Physiology2012;3:27. ">Lim 2012</a>; <a href="./references#CD012503-bbs2-0046" title="PanJ , LiX , PengY . Remote ischemic conditioning for acute ischemic stroke: dawn in the darkness. Reviews in the Neurosciences2016;27(5):501‐10. ">Pan 2016</a>). Therefore, although the three protective signal pathways are distinct, both neuronal and immunological pathways are linked to the humoral pathway. </p> </section> <section id="CD012503-sec-0041"> <h3 class="title" id="CD012503-sec-0041">Why it is important to do this review</h3> <p>RIC appears to be a well tolerated, cost‐effective, easily implemented strategy that has the potential to provide specialised care for any user (e.g. patients, caregivers, physicians) in any circumstance (e.g. home, ambulance, hospital). Previous Cochrane review authors have evaluated RIC in vascular and endovascular surgical procedures (<a href="./references#CD012503-bbs2-0034" title="DesaiM , GurusamyKS , GhanbariH , HamiltonG , SeifalianAM . Remote ischaemic preconditioning versus no remote ischaemic preconditioning for vascular and endovascular surgical procedures. Cochrane Database of Systematic Reviews2011, Issue 12. [DOI: 10.1002/14651858.CD008472.pub2] ">Desai 2011</a>), and RIC has also be evaluated in coronary artery bypass grafting and kidney ischaemia‐reperfusion injury in the<i>Cochrane Database of Systematic Reviews</i> (<a href="./references#CD012503-bbs2-0043" title="MentingTP , WeverKE , Ozdemir‐van BrunschotDMD , Van derVlietDJA , RoversMM , WarleM . Ischaemic preconditioning for the reduction of renal ischaemia reperfusion injury. Cochrane Database of Systematic Reviews2017, Issue 3. [DOI: 10.1002/14651858.CD010777.pub2] ">Menting 2017</a>; <a href="./references#CD012503-bbs2-0033" title="BenstoemC , StoppeC , LiakopoulosOJ , NeyJ , HasencleverD , MeybohmP , et al. Remote ischaemic preconditioning for coronary artery bypass grafting (with or without valve surgery). Cochrane Database of Systematic Reviews2017, Issue 5. [DOI: 10.1002/14651858.CD011719.pub3] ">Benstoem 2017</a>). RIC is developing as a neuroprotective strategy for ischaemic stroke prevention and treatment, and its implementation in clinical settings is increasing in many parts of the world. Several clinical trials have shown that RIC might reduce stroke recurrence and improve stroke outcomes, and that it is well tolerated without associated severe adverse events (<a href="./references#CD012503-bbs2-0002" title="HougaardKD , HjortN , ZeidlerD , SorensenL , NorgaardA , HansenTM , et al. Remote ischemic perconditioning as an adjunct therapy to thrombolysis in patients with acute ischemic stroke: a randomized trial. Stroke2014;45(159):67. [PUBMED: PMID: 24203849] ">Hougaard 2014</a>; <a href="./references#CD012503-bbs2-0003" title="MengR , AsmaroK , MengL , LiuY , MaC , XiC , et al. Upper limb ischemic preconditioning prevents recurrent stroke in intracranial arterial stenosis. Neurology2012;79(18):1853‐61. [PUBMED: PMID: 23035060] ">Meng 2012</a>; <a href="./references#CD012503-bbs2-0004" title="MengR , DingY , AsmaroK , BroganD , MengL , SuiM , et al. Ischemic conditioning is safe and effective for octo‐ and nonagenarians in stroke prevention and treatment. Neurotherapeutics2015;12(3):667‐77. [PUBMED: PMID: 25956401] ">Meng 2015</a>). However, existing evidence is insufficient to demonstrate the efficacy and safety of RIC. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD012503-sec-0042" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD012503-sec-0042"></div> <p>To assess the benefits and harms of RIC for preventing ischaemic stroke and for treating people with ischaemic stroke and those at risk for ischaemic stroke. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD012503-sec-0043" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD012503-sec-0043"></div> <section id="CD012503-sec-0044"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD012503-sec-0045"> <h4 class="title">Types of studies</h4> <p>We included all identified randomised controlled trials (RCTs) comparing remote ischaemic conditioning (RIC) versus non‐RIC (sham RIC or standard medical management alone) in people with ischaemic cerebrovascular diseases. We excluded uncontrolled trials as well as quasi‐RCTs where allocation to treatment or control was not concealed (e.g. allocation by alteration, open random number list, date of birth, day of the week, or hospital number). </p> </section> <section id="CD012503-sec-0046"> <h4 class="title">Types of participants</h4> <p>We included participants with any of the following: (1) acute ischaemic stroke diagnosed on the basis of the a combination of clinical examination findings and diagnostic test results or according to definitions for acute ischaemic stroke used by researchers to enrol patients in their RCTs; (2) chronic cerebral ischaemia (i.e.14 days after symptom onset) or gradual‐onset cerebral ischaemia (e.g. small vessel disease); (3) a definitive diagnosis of intracranial or extracranial cerebrovascular moderate and severe stenosis (i.e. &gt; 50%) or occlusion confirmed by computed tomography angiography (CTA), magnetic resonance angiography (MRA) or digital subtraction angiography (DSA). We excluded studies of participants undergoing cardiovascular intervention therapies, coronary artery bypass grafting, any other type of cardiac surgery, and people undergoing other surgeries, as the complication risk of ischaemic stroke was low in these patients. </p> </section> <section id="CD012503-sec-0047"> <h4 class="title">Types of interventions</h4> <p>The RIC protocol consisted of remote ischaemic preconditioning, remote ischaemic perconditioning and remote ischaemic postconditioning, which were the same procedure but divided based on the order of its initiation and the occurrence of ischaemia. A remote stimulus was applied to any organ (e.g. upper and lower limbs). This stimulus consisted of one or more cycles of brief ischaemia and reperfusion of varying duration. The control condition consisted of no intervention or standard medical management and shamRIC,which required application of a blood pressure cuff, tourniquet or other occlusive device without full interruption of blood flow. </p> </section> <section id="CD012503-sec-0048"> <h4 class="title">Types of outcome measures</h4> <section id="CD012503-sec-0049"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD012503-list-0001"> <li> <p>Ischaemic stroke or recurrent ischaemic stroke at completion of follow‐up</p> </li> <li> <p>Death or dependency (e.g. Barthel Index (BI) score ≤ 60, modified Rankin Scale (mRS) grade 3 to 6, defined by the trial author) at completion of follow‐up </p> </li> </ul> </p> </section> <section id="CD012503-sec-0050"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD012503-list-0002"> <li> <p>Stroke severity as measured by infarct volume, the National Institutes of Health Stroke Scale (NIHSS), the Canadian Neurological Scale (CNS), the Scandinavian Stroke Scale, the European Stroke Scale, the modified Rankin Scale (mRS) or other scales reported by trial authors </p> </li> <li> <p>Improvement in neurological impairment (e.g. NIHSS, mRS, CNS, other scales defined by trial authors) at completion of follow‐up </p> </li> <li> <p>Improvement in psychological and cognitive impairment (e.g. Mini‐Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA), Wechsler Memory Scale (WMS), Wechsler Memory Scale‐Revised (WMS‐R), Luria‐Nebraska Neuropsychological Battery (LNNB) Memory Scale, other scales defined by trial authors) at completion of follow‐up </p> </li> <li> <p>Cardiovascular events (e.g. acute myocardial infarction, angina)</p> </li> <li> <p>Haemorrhagic stroke (e.g. intracerebral haemorrhage, subarachnoid haemorrhage)</p> </li> <li> <p>Adverse events associated with RIC treatment (e.g. soft tissue injury, venous thrombosis, artery dissection, events reported by trial authors) </p> </li> </ul> </p> </section> </section> </section> <section id="CD012503-sec-0051"> <h3 class="title">Search methods for identification of studies</h3> <p>See the 'Specialised register' section in the <a href="http://onlinelibrary.wiley.com/o/cochrane/clabout/articles/STROKE/frame.html" target="_blank">Cochrane Stroke Group</a> module. We attempted to identify all relevant RCTs without restriction on language or publication status, and arranged translation of relevant papers where necessary. </p> <section id="CD012503-sec-0052"> <h4 class="title">Electronic searches</h4> <p>We searched the Cochrane Stroke Group Trials Register (16 January 2018), and the following electronic bibliographic databases. </p> <p> <ul id="CD012503-list-0003"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL; 2017, Issue 12) in the <i>Cochrane Library</i> (searched 16 January 2018) (<a href="./appendices#CD012503-sec-0124">Appendix 1</a>) </p> </li> <li> <p>MEDLINE Ovid (from 1946 to 16 January 2018) (<a href="./appendices#CD012503-sec-0125">Appendix 2</a>) </p> </li> <li> <p>Embase Ovid (from 1974 to 16 January 2018) (<a href="./appendices#CD012503-sec-0126">Appendix 3</a>) </p> </li> <li> <p>Science Citation Index Expanded (SCI‐EXPANDED) (Web of Science; 1950 to 10 January 2018) (<a href="./appendices#CD012503-sec-0127">Appendix 4</a>) </p> </li> <li> <p>Conference Proceedings Citation Index‐ Science (CPCI‐S) (Web of Science; 1950 to 10 January 2018) (<a href="./appendices#CD012503-sec-0127">Appendix 4</a>) </p> </li> <li> <p>China Biological Medicine Database (CBM; <a href="http://www.sinomed.ac.cn/" target="_blank">www.sinomed.ac.cn</a>/) (from 1978 to 10 January 2018) (<a href="./appendices#CD012503-sec-0128">Appendix 5</a>) </p> </li> <li> <p>China Doctoral Dissertations Full‐text Database (CDFD) (CNKI; from 1984 to 10 January 2018) (<a href="./appendices#CD012503-sec-0129">Appendix 6</a>) </p> </li> <li> <p>China Academic Journal Network Publishing Database (CAJD) (CNKI; from 1915 to 10 January 2018) (<a href="./appendices#CD012503-sec-0130">Appendix 7</a>) </p> </li> </ul> </p> <p>We developed the MEDLINE search strategy with the help of the Cochrane Stroke Group Information Specialist and adapted it for the other databases (<a href="./appendices#CD012503-sec-0125">Appendix 2</a>). </p> <p>We also conducted a search of the following research registers to identify ongoing matched trials (10 January 2018). </p> <p> <ul id="CD012503-list-0004"> <li> <p>World Health Organization (WHO) International Clinical Trials Registry Platform (<a href="http://www.who.int/trialsearch" target="_blank">www.who.int/trialsearch</a>) (<a href="./appendices#CD012503-sec-0131">Appendix 8</a>) </p> </li> <li> <p>ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov/" target="_blank">www.clinicaltrials.gov/</a>) (<a href="./appendices#CD012503-sec-0132">Appendix 9</a>) </p> </li> <li> <p>Stroke Trials Registry (<a href="http://www.strokecenter.org/trials/" target="_blank">www.strokecenter.org/trials/</a>) (<a href="./appendices#CD012503-sec-0133">Appendix 10</a>) </p> </li> <li> <p>ISRCTN Registry (<a href="http://www.isrctn.com/" target="_blank">www.isrctn.com</a>) (<a href="./appendices#CD012503-sec-0134">Appendix 11</a>) </p> </li> </ul> </p> </section> <section id="CD012503-sec-0053"> <h4 class="title">Searching other resources</h4> <p>In an effort to identify other published, unpublished, and ongoing studies, we searched reference lists of relevant trials, and relevant journals (<i>Brain Circulation</i> and <i>Conditioning Medicine</i>) and conference proceedings (European Stroke Conference, International Stroke Conference, and Neuroscience Conferences). We also searched for and contacted trialists and researchers in the field where necessary. </p> </section> </section> <section id="CD012503-sec-0054"> <h3 class="title" id="CD012503-sec-0054">Data collection and analysis</h3> <section id="CD012503-sec-0055"> <h4 class="title">Selection of studies</h4> <p>Two review authors (WBZ and JZ) independently screened titles and abstracts of records identified through literature search activities and excluded those that were obviously irrelevant and duplicated. We retrieved the full text of remaining articles, and the same two review authors (WBZ and JZ) independently screened full‐text articles to identify studies for inclusion or exclusion on the basis of our predetermined <a href="#CD012503-sec-0044">Criteria for considering studies for this review</a>. The two authors resolved any disagreements through discussion or by consulting a third author (RM). </p> </section> <section id="CD012503-sec-0056"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (WBZ and JZ) independently extracted and recorded study details on a data extraction form. We extracted the following data: methods, characteristics of participants, interventions, treatment duration, primary and secondary outcomes and time points reported. The same two authors cross‐checked all extracted data and resolved any differences in the extracted data by referring to the original articles and through discussion. We extracted data to allow an intention‐to‐treat (ITT) analysis (including all participants in the groups to which they were originally randomly allocated). </p> <p>For continuous outcomes, we used means and standard deviations for each group. If median and interquartile ranges were used in the original article, we translated them to means and standard deviations (<a href="./references#CD012503-bbs2-0054" title="WanX , WangW , LiuJ , TongT . Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Medical Research Methodology2014;14:135. ">Wan 2014</a>). For binary outcomes, we extracted the number of participants with the event in each group. </p> </section> <section id="CD012503-sec-0057"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (WBZ and JZ) independently assessed risk of bias for each study using the criteria outlined in the<i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012503-bbs2-0040" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org. ">Higgins 2011</a>). We resolved disagreements by discussion or by consultation with a third review author (RM) where necessary. We assessed risk of bias according to the following domains: selection bias; performance bias; detection bias; attrition bias; reporting bias and other possible bias. </p> <p>For each domain, we categorised each study as presenting 'low risk', 'high risk', or 'unclear risk' of bias and provided information from the study report, together with a justification for our judgement, in the 'Risk of bias' tables. </p> </section> <section id="CD012503-sec-0058"> <h4 class="title">Measures of treatment effect</h4> <p>We calculated risk ratios (RRs) with 95% confidence intervals (CIs) for dichotomous data (e.g., ischaemic stroke, recurrent ischaemic stroke, death, dependency, haemorrhagic stroke, cardiovascular events). For continuous data (e.g. scores from scales), we used mean differences (MDs) with 95% CIs for data measured in the same way between trials, and standardised mean differences (SMDs) with 95% CIs to combine data when different scales were used for measurement. We narratively described skewed data reported as medians and interquartile ranges. </p> </section> <section id="CD012503-sec-0059"> <h4 class="title">Unit of analysis issues</h4> <p>In most studies, the unit of analysis was the individual participant and a single measurement for each outcome was collected and analysed. However, for cross‐over trials, the unit of analysis included only the first phase in the analysis. For cluster‐randomised trials, the unit of analysis was the cluster. </p> </section> <section id="CD012503-sec-0060"> <h4 class="title">Dealing with missing data</h4> <p>We carried out analyses according to the ITT principle: we used the number of initially randomised individuals as the denominator. If data were missing, we contacted the corresponding author or co‐authors through the address or email given in the publication. When this was not possible, we calculated best‐ and worst‐case scenarios for dichotomous data: the best‐case scenario would mean participants with missing data were alive or achieved dependence or did not experience stroke, and the worst‐case scenario would mean that participants with missing data were dead or experienced stroke or did not achieve dependence. </p> </section> <section id="CD012503-sec-0061"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed heterogeneity between study results using the I<sup>2</sup> statistic. We defined a value greater than 50% as indicating substantial heterogeneity. </p> </section> <section id="CD012503-sec-0062"> <h4 class="title">Assessment of reporting biases</h4> <p>We had intended to use funnel plots to assess the potential existence of reporting bias if more than 10 studies were included in this review. However, because we only seven included studies, we assessed reporting bias qualitatively on the basis of the study characteristics. </p> </section> <section id="CD012503-sec-0063"> <h4 class="title">Data synthesis</h4> <p>We conducted a meta‐analysis using Review Manager 5 (<a href="./references#CD012503-bbs2-0050" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>). We used RR as a measure of effect for binary outcomes and MD or SMD as a measure of effect for continuous outcomes. We used a random‐effects model to better estimate the effect size of different studies, regardless of whether heterogeneity was significant. </p> <section id="CD012503-sec-0064"> <h5 class="title">GRADE and 'Summary of findings' table</h5> <p>We summarised the evidence by creating 'Summary of findings' tables using GRADEproGDT (<a href="https://gradepro.org/" target="_blank">https://gradepro.org/</a>), in which we imported data from Review Manager 5. We used the GRADE approach to assess the quality of evidence as high, moderate, low, or very low, based on the following five considerations: study limitations, imprecision, consistency of effect, indirectness and publication bias (<a href="./references#CD012503-bbs2-0040" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org. ">Higgins 2011</a>). The table presents results and our assessments of the quality of evidence for the main outcomes. </p> </section> </section> <section id="CD012503-sec-0065"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We had intended to performed subgroup analysis to investigate heterogeneity by analysing differences in the number of RIC cycles and their length, the position of RIC (upper versus lower limb, unilateral versus bilateral), and length of RIC treatment (fractionated versus continuous). However, in this review only seven trials were eligible for analysis: three studies for the analysis of RIC for preventing ischaemic stroke, and another four studies for the analysis of RIC for treating ischaemic stroke. Given the limited number of included studies, there were not enough data for subgroup analysis. </p> </section> <section id="CD012503-sec-0066"> <h4 class="title">Sensitivity analysis</h4> <p>We had intended to perform sensitivity analyses if the results were substantially heterogeneous, by 1) excluding studies with inadequate allocation concealment; 2) excluding studies that did not use blinding; 3) excluding studies in which loss to follow‐up was not reported or was greater than 10%; 4) excluding unpublished studies; 5) excluding studies that did not use sham as a comparison; and 6) excluding long studies, large studies or those using imputed data to determine their influence on study results. However, we did not perform any sensitivity analyses because of the limited number of included studies, and no substantial heterogeneity was found in this review. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD012503-sec-0067" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD012503-sec-0067"></div> <section id="CD012503-sec-0068"> <h3 class="title">Description of studies</h3> <p>A detailed description of all studies can be found in <a href="./references#CD012503-sec-0143" title="">Characteristics of included studies</a>, <a href="./references#CD012503-sec-0144" title="">Characteristics of excluded studies</a>, and <a href="./references#CD012503-sec-0145" title="">Characteristics of ongoing studies</a>. </p> <section id="CD012503-sec-0069"> <h4 class="title">Results of the search</h4> <p>We identified a total of 8765 records from database searching in January 2018. After removing 1668 duplicates, 7097 records remained, which we screened and excluded 7066 records. We retrieved 31 full‐text articles and abstracts and assessed them for eligibility. Finally, we identified seven trials and assessed them for eligibility as per protocol with refined inclusion criteria. We excluded 16 studies with reasons (see <a href="./references#CD012503-sec-0144" title="">Characteristics of excluded studies</a>), and identified eight ongoing studies. We present details of the seven included trials in <a href="./references#CD012503-sec-0143" title="">Characteristics of included studies</a>. For an illustration of these results, please see the study flow diagram (<a href="#CD012503-fig-0001">Figure 1</a>). </p> <div class="figure" id="CD012503-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD012503-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012503.pub2/media/CDSR/CD012503/image_n/nCD012503-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD012503-sec-0070"> <h4 class="title">Included studies</h4> <p>Seven trials met our inclusion criteria. The first trial was a single‐centre trial conducted in the UK (<a href="./references#CD012503-bbs2-0001" title="EnglandT , HedstromA , O'SullivanS , DonnellyR , SpriggN , BathP . Remote ischaemic conditioning after stroke trial (RECAST). International Journal of Stroke2016;11 Suppl 4:6. ">England 2016</a>). The trial compared remote ischaemic conditioning (RIC) with sham RIC in 26 participants (13 in each group) with acute ischaemic stroke. RIC and sham RIC were started within 24 hours of stroke onset and performed manually using a standard upper arm blood pressure cuff in the nonparetic arm. RIC consisted of four cycles of five minutes' inflation (20 mmHg above systolic blood pressure) and five minutes' deflation; and sham RIC consisted of four cycles of five minutes' inflation (30 mmHg) and five minutes' deflation. The primary outcome was tolerability and feasibility of RIC after acute ischaemic stroke, and the duration of follow‐up was 90 days. </p> <p>The second trial was a single‐centre trial conducted in Denmark (<a href="./references#CD012503-bbs2-0002" title="HougaardKD , HjortN , ZeidlerD , SorensenL , NorgaardA , HansenTM , et al. Remote ischemic perconditioning as an adjunct therapy to thrombolysis in patients with acute ischemic stroke: a randomized trial. Stroke2014;45(159):67. [PUBMED: PMID: 24203849] ">Hougaard 2014</a>). The trial compared intravenous thrombolysis plus RIC with intravenous thrombolysis alone in 285 participants with acute ischaemic stroke. Because of the imbalanced randomisation and large number of participants excluded from the analysis after randomisation, there were unbalanced numbers of participants between the two groups (160 in the intervention group, and 125 in the control group). RIC was started in the ambulance and induced by four inflations of a standard upper limb blood pressure cuff to either 200 mmHg or 25 mmHg above the systolic blood pressure, each lasting five minutes and separated by five minutes of cuff deflation. The primary outcome was the penumbra salvage, and the duration of follow‐up was 90 days. </p> <p>The third trial was conducted in two centres in China (<a href="./references#CD012503-bbs2-0003" title="MengR , AsmaroK , MengL , LiuY , MaC , XiC , et al. Upper limb ischemic preconditioning prevents recurrent stroke in intracranial arterial stenosis. Neurology2012;79(18):1853‐61. [PUBMED: PMID: 23035060] ">Meng 2012</a>). The trial compared standard medical treatment plus RIC and standard medical treatment alone in 103 participants (51 in the intervention group and 52 in the control group) with symptomatic intracranial artery stenosis. RIC, consisting of five cycles of bilateral arms ischaemia (induced by inflating tourniquets to 200 mmHg) for five minutes followed by reperfusion for another five minutes, was performed twice daily for a total of 300 consecutive days. Standard medical treatment including antiplatelet agents, lipid control agents, and antidiabetic agents (if necessary). The primary outcome was time point of the first stroke recurrence event, and the duration of follow up was 300 days. </p> <p>The fourth trial was a single‐centre trial conducted in China (<a href="./references#CD012503-bbs2-0004" title="MengR , DingY , AsmaroK , BroganD , MengL , SuiM , et al. Ischemic conditioning is safe and effective for octo‐ and nonagenarians in stroke prevention and treatment. Neurotherapeutics2015;12(3):667‐77. [PUBMED: PMID: 25956401] ">Meng 2015</a>). The trial compared RIC and sham RIC in 79 octogenarian and nonagenarian participants (40 in the intervention group and 39 in the control group) with symptomatic intracerebral artery stenosis. RIC consisted of five cycles of simultaneous bilateral arms ischaemia (induced by inflating tourniquets to 200 mmHg) for five minutes followed by reperfusion for another five minutes. Sham RIC consisted of five cycles of bilateral arms ischaemia (induced by inflating tourniquets to 30 mmHg) for five minutes, followed by reperfusion for another five minutes. Both RIC and sham RIC were performed for 180 consecutive days. Medical management included either clopidogrel 75 mg/day in combination with atorvastatin 20 mg/day or aspirin 100 mg/day and clopidogrel 75 mg/day in combination with atorvastatin 20 mg/day. The duration of follow‐up was 180 days. </p> <p>The fifth trial was a single‐centre trial conducted in China (<a href="./references#CD012503-bbs2-0005" title="MiT , YuF , JiX , SunY , QuD . The interventional effect of remote ischemic preconditioning on cerebral small vessel disease: a pilot randomized clinical trial. European Neurology2016;76(1‐2):28‐34. [PUBMED: PMID: 27351719] ">Mi 2016</a>). The trial compared RIC and sham RIC in 17 participants (nine in the intervention group and eight in the control group) with cerebral small vessel disease. Both RIC and sham RIC were achieved using an automated cuff inflator placed on bilateral arms that were inflated to 200 mmHg and 50 mmHg respectively. Both RIC and sham RIC consisted of five cycles of five minutes' ischaemia follow by five minutes' reperfusion. All participants were required to receive RIC or sham RIC treatment twice daily for one year. The primary outcome was changes in brain lesions, evaluated by the number of lacunar infarctions and white matter lesions volume, and the duration of follow‐up was one year. </p> <p>The sixth trial was a single‐centre trial conducted in China (<a href="./references#CD012503-bbs2-0006" title="WangY , MengR , SongH , LiuG , HuaY , CuiD , et al. Remote ischemic conditioning may improve outcomes of patients with cerebral small‐vessel disease. Stroke2017;48(11):3064‐72. [PUBMED: PMID: 29042490 ] ">Wang 2017</a>). The trial compared RIC and sham RIC in 36 participants (18 in the intervention group and 18 in the control group) with cerebral small vessel disease‐related mild cognitive impairment. Both RIC and sham RIC were achieved using an automated cuff inflator placed on bilateral arms that were inflated to 200 mmHg and 50 mmHg respectively. Both RIC and sham RIC consisted of five cycles of five minutes' ischaemia follow by five minutes' reperfusion. All participants were required to receive RIC or sham RIC treatment twice daily for one year. The primary outcome was the change of brain lesions, and the follow‐up duration was one year. </p> <p>The seventh trial was a single‐centre trial conducted in China (<a href="./references#CD012503-bbs2-0007" title="ZhaoW , MengR , MaC , HouB , JiaoL , ZhuF , et al. Safety and efficacy of remote ischemic preconditioning in patients with severe carotid artery stenosis before carotid artery stenting: a proof‐of‐concept, randomized controlled trial. Circulation2017;135(14):1325‐35. [PUBMED: PMID: 28174194] ">Zhao 2017</a>). The trial compared RIC plus standard medical treatment, sham RIC plus standard medical treatment and standard medical treatment alone in 189 participants (63 in each group) with severe carotid artery stenosis. RIC and sham RIC consisted of five cycles of bilateral arms ischaemia for five minutes, followed by reperfusion for another five minutes, and they were performed twice daily for two weeks before carotid stenting. Both RIC and sham RIC procedures were performed by using an electric autocontrol device with cuffs that inflated to a pressure of 200 mmHg and 60 mmHg respectively during the ischaemic period. The primary outcomes were the presence of one or more new brain lesions on diffusion weighted imaging (DWI) within 48 hours after carotid artery stenting, and the incidence of clinical events (i.e. ischaemic stroke, transient ischaemic attach (TIA), acute myocardial infarction, haemorrhagic stroke, hyperperfusion syndrome, and death) within six months after stenting. The duration of follow‐up was six months. </p> </section> <section id="CD012503-sec-0071"> <h4 class="title">Excluded studies</h4> <p>We excluded 16 studies from this review. The <a href="./references#CD012503-sec-0144" title="">Characteristics of excluded studies</a> table provides summary details. </p> <p>We excluded seven studies because the participants underwent percutaneous coronary intervention or cardiac surgery (<a href="./references#CD012503-bbs2-0008" title="ChoYJ , LeeEH , LeeK , KimTK , HongDM , ChinJH , et al. Long‐term clinical outcomes of remote ischemic preconditioning and postconditioning outcome (rispo) trial in patients undergoing cardiac surgery. International Journal of Cardiology2017;231:84‐9. ">Cho 2017</a>; <a href="./references#CD012503-bbs2-0009" title="CoverdaleNS , HamiltonA , PetsikasD , McClureRS , MalikP , MilneB , et al. Remote ischemic preconditioning in high‐risk cardiovascular surgery patients: a randomized‐controlled trial. http://www.semthorcardiovascsurg.com/article/S1043‐0679(17)30238‐1/fulltext2017. ">Coverdale 2017</a>; <a href="./references#CD012503-bbs2-0010" title="DaviesWR , BrownAJ , WatsonW , McCormickLM , WestNEJ , DutkaDP , et al. Remote ischemic preconditioning improves outcome at 6 years after elective percutaneous coronary intervention: the CRISP stent trial long‐term follow‐up. Circulation: Cardiovascular Interventions2013;6(3):246‐51. ">Davies 2013</a>; <a href="./references#CD012503-bbs2-0012" title="HooleSP , HeckPM , SharplesL , KhanSN , DuehmkeR , DensemCG , et al. Cardiac remote ischemic preconditioning in coronary stenting (CRISP Stent) study: a prospective, randomized control trial. Circulation2009;119(6):820‐7. ">Hoole 2009</a>; <a href="./references#CD012503-bbs2-0013" title="HudetzJ , PattersonK , IqbalZ , GandhiS , PagelP . Remote ischemic preconditioning prevents deterioration of short‐term postoperative cognitive function after cardiac surgery using cardiopulmonary bypass: results of a pilot investigation. Journal of Cardiothoracic and Vascular Anesthesia2014;29(2):382‐8. ">Hudetz 2014</a>; <a href="./references#CD012503-bbs2-0021" title="SlothAD , SchmidtMR , MunkK , KharbandaRK , RedingtonAN , SchmidtM , et al. Improved long‐term clinical outcomes in patients with ST‐elevation myocardial infarction undergoing remote ischaemic conditioning as an adjunct to primary percutaneous coronary intervention. European Heart Journal2014;35(3):168‐75. ">Sloth 2014</a>; <a href="./references#CD012503-bbs2-0023" title="ZhongH , GaoZ , ChenM , ZhaoJ , WangF , LiL , et al. Cardioprotective effect of remote ischemic postconditioning on children undergoing cardiac surgery: a randomized controlled trial. Paediatric Anaesthesia2013;23(8):726‐33. ">Zhong 2013</a>). We excluded one study because the included participants underwent transfemoral transcatheter aortic valve implantation (<a href="./references#CD012503-bbs2-0017" title="KahlertP , HildebrandtHA , PatsalisPC , Al‐RashidF , JanosiRA , NensaF , et al. No protection of heart, kidneys and brain by remote ischemic preconditioning before transfemoral transcatheter aortic valve implantation: interim‐analysis of a randomized single‐blinded, placebo‐controlled, single‐center trial. International Journal of Cardiology2017;231(3):248‐54. ">Kahlert 2017</a>). One study randomised participants treated with major vascular surgery, including carotid endarterectomy; we excluded it because we did not obtain the data on participants treated with carotid endarterectomy after emailing the author (<a href="./references#CD012503-bbs2-0011" title="HealyDA , BoyleE , McCartanD , BourkeM , MedaniM , FergusonJ , et al. A multicenter pilot randomized controlled trial of remote ischemic preconditioning in major vascular surgery. Vascular and Endovascular Surgery2015;49(8):220‐7. ">Healy 2015</a>). We excluded four studies because they did not assess ischaemic stroke in their outcome assessment (<a href="./references#CD012503-bbs2-0015" title="JingG , ZhengL . Protective effects of remote ischemic preconditioning on cerebral injury in patients undergoing cardiac valve replacement with CPB. Journal of Xian Jiaotong University2011;32(4):473‐6. ">Jing 2011</a>; <a href="./references#CD012503-bbs2-0018" title="MengR , ZhaoW , LiS , SuiM , ZhouD , WuW , et al. Long‐term regular remote ischemic conditioning promotes arterial collateral opening and reconstruction in patients with intracranial atherosclerotic stenosis. Stroke2017;48:A76‐A76. ">Meng 2017</a>; <a href="./references#CD012503-bbs2-0020" title="SalesAHA , BarzM , BetteS , WiestlerB , RyangYM , MeyerB , et al. Impact of ischemic preconditioning on surgical treatment of brain tumors: a single‐center, randomized, double‐blind, controlled trial. BMC Medicine2017;15(1):137. ">Sales 2017</a>; <a href="./references#CD012503-bbs2-0022" title="WalshSR , NouraeiSA , TangTY , SadatU , CarpenterRH , GauntME . Remote ischemic preconditioning for cerebral and cardiac protection during carotid endarterectomy: results from a pilot randomized clinical trial. Vascular and Endovascular Surgery2010;44(6):434‐9. ">Walsh 2010</a>). Another study was not a randomised controlled trial (<a href="./references#CD012503-bbs2-0016" title="JosephB , PanditV , ZangbarB , KulvatunyouN , KhalilM , TangA , et al. Secondary brain injury in trauma patients: the effects of remote ischemic conditioning. Journal of Trauma and Acute Care Surgery2015;78(4):698‐705. ">Joseph 2015</a>), and another study has passed the completion date but the status has not been verified after more than two years, and no paper or results have been published to date (<a href="./references#CD012503-bbs2-0019" title="NCT01672515 . Protective effects of remote limb ischemic preconditioning on acute cerebral infarction. https://clinicaltrials.gov/ct2/show/NCT01672515 (accessed 10 January 2018). ">NCT01672515</a>). We excluded one study because the comparison was between healthy people and patients (<a href="./references#CD012503-bbs2-0014" title="HyngstromA , SchmitBD , GuttermanDD , DurandMJ . Ischemic preconditioning as a method to improve motor function post stroke. Archives of Physical Medicine and Rehabilitation2016;97(10):819 (Abst. 804). ">Hyngstrom 2016</a>). </p> </section> </section> <section id="CD012503-sec-0072"> <h3 class="title">Risk of bias in included studies</h3> <p>The 'Risk of bias' assessments for all included studies are summarised in <a href="#CD012503-fig-0002">Figure 2</a> and <a href="#CD012503-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD012503-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD012503-fig-0002" src="/cdsr/doi/10.1002/14651858.CD012503.pub2/media/CDSR/CD012503/image_n/nCD012503-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD012503-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD012503-fig-0003" src="/cdsr/doi/10.1002/14651858.CD012503.pub2/media/CDSR/CD012503/image_n/nCD012503-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD012503-sec-0073"> <h4 class="title">Allocation</h4> <p>The method of randomisation was described and considered adequate with low risk of bias in six included studies (<a href="./references#CD012503-bbs2-0001" title="EnglandT , HedstromA , O'SullivanS , DonnellyR , SpriggN , BathP . Remote ischaemic conditioning after stroke trial (RECAST). International Journal of Stroke2016;11 Suppl 4:6. ">England 2016</a>; <a href="./references#CD012503-bbs2-0002" title="HougaardKD , HjortN , ZeidlerD , SorensenL , NorgaardA , HansenTM , et al. Remote ischemic perconditioning as an adjunct therapy to thrombolysis in patients with acute ischemic stroke: a randomized trial. Stroke2014;45(159):67. [PUBMED: PMID: 24203849] ">Hougaard 2014</a>; <a href="./references#CD012503-bbs2-0003" title="MengR , AsmaroK , MengL , LiuY , MaC , XiC , et al. Upper limb ischemic preconditioning prevents recurrent stroke in intracranial arterial stenosis. Neurology2012;79(18):1853‐61. [PUBMED: PMID: 23035060] ">Meng 2012</a>; <a href="./references#CD012503-bbs2-0004" title="MengR , DingY , AsmaroK , BroganD , MengL , SuiM , et al. Ischemic conditioning is safe and effective for octo‐ and nonagenarians in stroke prevention and treatment. Neurotherapeutics2015;12(3):667‐77. [PUBMED: PMID: 25956401] ">Meng 2015</a>; <a href="./references#CD012503-bbs2-0005" title="MiT , YuF , JiX , SunY , QuD . The interventional effect of remote ischemic preconditioning on cerebral small vessel disease: a pilot randomized clinical trial. European Neurology2016;76(1‐2):28‐34. [PUBMED: PMID: 27351719] ">Mi 2016</a>; <a href="./references#CD012503-bbs2-0007" title="ZhaoW , MengR , MaC , HouB , JiaoL , ZhuF , et al. Safety and efficacy of remote ischemic preconditioning in patients with severe carotid artery stenosis before carotid artery stenting: a proof‐of‐concept, randomized controlled trial. Circulation2017;135(14):1325‐35. [PUBMED: PMID: 28174194] ">Zhao 2017</a>). Four studies reported that the random sequence was generated by using computer‐generated random number sequence (<a href="./references#CD012503-bbs2-0003" title="MengR , AsmaroK , MengL , LiuY , MaC , XiC , et al. Upper limb ischemic preconditioning prevents recurrent stroke in intracranial arterial stenosis. Neurology2012;79(18):1853‐61. [PUBMED: PMID: 23035060] ">Meng 2012</a>; <a href="./references#CD012503-bbs2-0004" title="MengR , DingY , AsmaroK , BroganD , MengL , SuiM , et al. Ischemic conditioning is safe and effective for octo‐ and nonagenarians in stroke prevention and treatment. Neurotherapeutics2015;12(3):667‐77. [PUBMED: PMID: 25956401] ">Meng 2015</a>; <a href="./references#CD012503-bbs2-0005" title="MiT , YuF , JiX , SunY , QuD . The interventional effect of remote ischemic preconditioning on cerebral small vessel disease: a pilot randomized clinical trial. European Neurology2016;76(1‐2):28‐34. [PUBMED: PMID: 27351719] ">Mi 2016</a>; <a href="./references#CD012503-bbs2-0007" title="ZhaoW , MengR , MaC , HouB , JiaoL , ZhuF , et al. Safety and efficacy of remote ischemic preconditioning in patients with severe carotid artery stenosis before carotid artery stenting: a proof‐of‐concept, randomized controlled trial. Circulation2017;135(14):1325‐35. [PUBMED: PMID: 28174194] ">Zhao 2017</a>). One study reported that the randomisation was performed by drawing from a large number of sealed opaque envelopes (<a href="./references#CD012503-bbs2-0002" title="HougaardKD , HjortN , ZeidlerD , SorensenL , NorgaardA , HansenTM , et al. Remote ischemic perconditioning as an adjunct therapy to thrombolysis in patients with acute ischemic stroke: a randomized trial. Stroke2014;45(159):67. [PUBMED: PMID: 24203849] ">Hougaard 2014</a>). One study reported that the randomisation was generated by minimisation (<a href="./references#CD012503-bbs2-0001" title="EnglandT , HedstromA , O'SullivanS , DonnellyR , SpriggN , BathP . Remote ischaemic conditioning after stroke trial (RECAST). International Journal of Stroke2016;11 Suppl 4:6. ">England 2016</a>). Another study only reported that randomisation was performed by an independent statistician; the details were not reported, therefore we judged the risk of bias as unclear (<a href="./references#CD012503-bbs2-0006" title="WangY , MengR , SongH , LiuG , HuaY , CuiD , et al. Remote ischemic conditioning may improve outcomes of patients with cerebral small‐vessel disease. Stroke2017;48(11):3064‐72. [PUBMED: PMID: 29042490 ] ">Wang 2017</a>). </p> <p>Allocation concealment was adequate with low risk of bias in three studies, one of which used a web‐based randomisation method (<a href="./references#CD012503-bbs2-0001" title="EnglandT , HedstromA , O'SullivanS , DonnellyR , SpriggN , BathP . Remote ischaemic conditioning after stroke trial (RECAST). International Journal of Stroke2016;11 Suppl 4:6. ">England 2016</a>), and two of which used sequentially numbered, opaque, sealed envelopes (<a href="./references#CD012503-bbs2-0004" title="MengR , DingY , AsmaroK , BroganD , MengL , SuiM , et al. Ischemic conditioning is safe and effective for octo‐ and nonagenarians in stroke prevention and treatment. Neurotherapeutics2015;12(3):667‐77. [PUBMED: PMID: 25956401] ">Meng 2015</a>; <a href="./references#CD012503-bbs2-0007" title="ZhaoW , MengR , MaC , HouB , JiaoL , ZhuF , et al. Safety and efficacy of remote ischemic preconditioning in patients with severe carotid artery stenosis before carotid artery stenting: a proof‐of‐concept, randomized controlled trial. Circulation2017;135(14):1325‐35. [PUBMED: PMID: 28174194] ">Zhao 2017</a>). Allocation concealment was unclear for three trials which only reported that the assignments were sealed, but not whether the assignment was sequentially numbered (<a href="./references#CD012503-bbs2-0002" title="HougaardKD , HjortN , ZeidlerD , SorensenL , NorgaardA , HansenTM , et al. Remote ischemic perconditioning as an adjunct therapy to thrombolysis in patients with acute ischemic stroke: a randomized trial. Stroke2014;45(159):67. [PUBMED: PMID: 24203849] ">Hougaard 2014</a>; <a href="./references#CD012503-bbs2-0005" title="MiT , YuF , JiX , SunY , QuD . The interventional effect of remote ischemic preconditioning on cerebral small vessel disease: a pilot randomized clinical trial. European Neurology2016;76(1‐2):28‐34. [PUBMED: PMID: 27351719] ">Mi 2016</a>; <a href="./references#CD012503-bbs2-0006" title="WangY , MengR , SongH , LiuG , HuaY , CuiD , et al. Remote ischemic conditioning may improve outcomes of patients with cerebral small‐vessel disease. Stroke2017;48(11):3064‐72. [PUBMED: PMID: 29042490 ] ">Wang 2017</a>). One study did not report the details of allocation (<a href="./references#CD012503-bbs2-0003" title="MengR , AsmaroK , MengL , LiuY , MaC , XiC , et al. Upper limb ischemic preconditioning prevents recurrent stroke in intracranial arterial stenosis. Neurology2012;79(18):1853‐61. [PUBMED: PMID: 23035060] ">Meng 2012</a>). </p> </section> <section id="CD012503-sec-0074"> <h4 class="title">Blinding</h4> <p>Because of the nature of RIC treatment, if no sham RIC treatment was used, it was impossible to blind the participants. Therefore, we judged two studies as being at high risk of bias (<a href="./references#CD012503-bbs2-0002" title="HougaardKD , HjortN , ZeidlerD , SorensenL , NorgaardA , HansenTM , et al. Remote ischemic perconditioning as an adjunct therapy to thrombolysis in patients with acute ischemic stroke: a randomized trial. Stroke2014;45(159):67. [PUBMED: PMID: 24203849] ">Hougaard 2014</a>; <a href="./references#CD012503-bbs2-0003" title="MengR , AsmaroK , MengL , LiuY , MaC , XiC , et al. Upper limb ischemic preconditioning prevents recurrent stroke in intracranial arterial stenosis. Neurology2012;79(18):1853‐61. [PUBMED: PMID: 23035060] ">Meng 2012</a>), and four as being at low risk of bias (<a href="./references#CD012503-bbs2-0004" title="MengR , DingY , AsmaroK , BroganD , MengL , SuiM , et al. Ischemic conditioning is safe and effective for octo‐ and nonagenarians in stroke prevention and treatment. Neurotherapeutics2015;12(3):667‐77. [PUBMED: PMID: 25956401] ">Meng 2015</a>; <a href="./references#CD012503-bbs2-0001" title="EnglandT , HedstromA , O'SullivanS , DonnellyR , SpriggN , BathP . Remote ischaemic conditioning after stroke trial (RECAST). International Journal of Stroke2016;11 Suppl 4:6. ">England 2016</a>; <a href="./references#CD012503-bbs2-0005" title="MiT , YuF , JiX , SunY , QuD . The interventional effect of remote ischemic preconditioning on cerebral small vessel disease: a pilot randomized clinical trial. European Neurology2016;76(1‐2):28‐34. [PUBMED: PMID: 27351719] ">Mi 2016</a>; <a href="./references#CD012503-bbs2-0006" title="WangY , MengR , SongH , LiuG , HuaY , CuiD , et al. Remote ischemic conditioning may improve outcomes of patients with cerebral small‐vessel disease. Stroke2017;48(11):3064‐72. [PUBMED: PMID: 29042490 ] ">Wang 2017</a>). One study was comprised of three groups (RIC group, sham RIC group, and control group); although sham RIC was included in the study, it was also impossible to blind the participants (<a href="./references#CD012503-bbs2-0007" title="ZhaoW , MengR , MaC , HouB , JiaoL , ZhuF , et al. Safety and efficacy of remote ischemic preconditioning in patients with severe carotid artery stenosis before carotid artery stenting: a proof‐of‐concept, randomized controlled trial. Circulation2017;135(14):1325‐35. [PUBMED: PMID: 28174194] ">Zhao 2017</a>). Therefore, we also judged this trial as having high risk of performance bias. </p> <p>One study was an outcome‐blinded, placebo‐controlled trial (<a href="./references#CD012503-bbs2-0001" title="EnglandT , HedstromA , O'SullivanS , DonnellyR , SpriggN , BathP . Remote ischaemic conditioning after stroke trial (RECAST). International Journal of Stroke2016;11 Suppl 4:6. ">England 2016</a>). All other studies reported that the outcome assessors were blinded to the treatment protocol (<a href="./references#CD012503-bbs2-0002" title="HougaardKD , HjortN , ZeidlerD , SorensenL , NorgaardA , HansenTM , et al. Remote ischemic perconditioning as an adjunct therapy to thrombolysis in patients with acute ischemic stroke: a randomized trial. Stroke2014;45(159):67. [PUBMED: PMID: 24203849] ">Hougaard 2014</a>; <a href="./references#CD012503-bbs2-0003" title="MengR , AsmaroK , MengL , LiuY , MaC , XiC , et al. Upper limb ischemic preconditioning prevents recurrent stroke in intracranial arterial stenosis. Neurology2012;79(18):1853‐61. [PUBMED: PMID: 23035060] ">Meng 2012</a>; <a href="./references#CD012503-bbs2-0004" title="MengR , DingY , AsmaroK , BroganD , MengL , SuiM , et al. Ischemic conditioning is safe and effective for octo‐ and nonagenarians in stroke prevention and treatment. Neurotherapeutics2015;12(3):667‐77. [PUBMED: PMID: 25956401] ">Meng 2015</a>; <a href="./references#CD012503-bbs2-0005" title="MiT , YuF , JiX , SunY , QuD . The interventional effect of remote ischemic preconditioning on cerebral small vessel disease: a pilot randomized clinical trial. European Neurology2016;76(1‐2):28‐34. [PUBMED: PMID: 27351719] ">Mi 2016</a>; <a href="./references#CD012503-bbs2-0006" title="WangY , MengR , SongH , LiuG , HuaY , CuiD , et al. Remote ischemic conditioning may improve outcomes of patients with cerebral small‐vessel disease. Stroke2017;48(11):3064‐72. [PUBMED: PMID: 29042490 ] ">Wang 2017</a>; <a href="./references#CD012503-bbs2-0007" title="ZhaoW , MengR , MaC , HouB , JiaoL , ZhuF , et al. Safety and efficacy of remote ischemic preconditioning in patients with severe carotid artery stenosis before carotid artery stenting: a proof‐of‐concept, randomized controlled trial. Circulation2017;135(14):1325‐35. [PUBMED: PMID: 28174194] ">Zhao 2017</a>). We therefore judged all the trials as having low risk of detection bias. </p> </section> <section id="CD012503-sec-0075"> <h4 class="title">Incomplete outcome data</h4> <p>We judged two studies as having low risk of attrition bias as there were no participants lost to follow‐up during the study period (<a href="./references#CD012503-bbs2-0001" title="EnglandT , HedstromA , O'SullivanS , DonnellyR , SpriggN , BathP . Remote ischaemic conditioning after stroke trial (RECAST). International Journal of Stroke2016;11 Suppl 4:6. ">England 2016</a>; <a href="./references#CD012503-bbs2-0005" title="MiT , YuF , JiX , SunY , QuD . The interventional effect of remote ischemic preconditioning on cerebral small vessel disease: a pilot randomized clinical trial. European Neurology2016;76(1‐2):28‐34. [PUBMED: PMID: 27351719] ">Mi 2016</a>). We judged three trials as having high risk of attrition bias because of the following losses to follow‐up: 35 out of 103 (34.0%) participants (<a href="./references#CD012503-bbs2-0003" title="MengR , AsmaroK , MengL , LiuY , MaC , XiC , et al. Upper limb ischemic preconditioning prevents recurrent stroke in intracranial arterial stenosis. Neurology2012;79(18):1853‐61. [PUBMED: PMID: 23035060] ">Meng 2012</a>); 21 out of 79 (26.6%) participants (<a href="./references#CD012503-bbs2-0004" title="MengR , DingY , AsmaroK , BroganD , MengL , SuiM , et al. Ischemic conditioning is safe and effective for octo‐ and nonagenarians in stroke prevention and treatment. Neurotherapeutics2015;12(3):667‐77. [PUBMED: PMID: 25956401] ">Meng 2015</a>); and 6 out of 36 (16.7%) participants (<a href="./references#CD012503-bbs2-0006" title="WangY , MengR , SongH , LiuG , HuaY , CuiD , et al. Remote ischemic conditioning may improve outcomes of patients with cerebral small‐vessel disease. Stroke2017;48(11):3064‐72. [PUBMED: PMID: 29042490 ] ">Wang 2017</a>). We judged the two remaining studies as having high risk of attrition bias because 158 out of 443 (35.7%) participants were excluded in the as‐treated analyses (<a href="./references#CD012503-bbs2-0002" title="HougaardKD , HjortN , ZeidlerD , SorensenL , NorgaardA , HansenTM , et al. Remote ischemic perconditioning as an adjunct therapy to thrombolysis in patients with acute ischemic stroke: a randomized trial. Stroke2014;45(159):67. [PUBMED: PMID: 24203849] ">Hougaard 2014</a>); and 27 out of 189 (14.3%) participants were lost to the analyses of imaging and 42 out of 189 (22.2%) participants were lost to the analyses of clinical events (<a href="./references#CD012503-bbs2-0007" title="ZhaoW , MengR , MaC , HouB , JiaoL , ZhuF , et al. Safety and efficacy of remote ischemic preconditioning in patients with severe carotid artery stenosis before carotid artery stenting: a proof‐of‐concept, randomized controlled trial. Circulation2017;135(14):1325‐35. [PUBMED: PMID: 28174194] ">Zhao 2017</a>). </p> </section> <section id="CD012503-sec-0076"> <h4 class="title">Selective reporting</h4> <p>All included studies registered their study protocols in one of the clinical trial registration websites, and all predefined study outcomes were published. Therefore, we judged all included studies as low risk of reporting bias (<a href="./references#CD012503-bbs2-0001" title="EnglandT , HedstromA , O'SullivanS , DonnellyR , SpriggN , BathP . Remote ischaemic conditioning after stroke trial (RECAST). International Journal of Stroke2016;11 Suppl 4:6. ">England 2016</a>; <a href="./references#CD012503-bbs2-0002" title="HougaardKD , HjortN , ZeidlerD , SorensenL , NorgaardA , HansenTM , et al. Remote ischemic perconditioning as an adjunct therapy to thrombolysis in patients with acute ischemic stroke: a randomized trial. Stroke2014;45(159):67. [PUBMED: PMID: 24203849] ">Hougaard 2014</a>; <a href="./references#CD012503-bbs2-0003" title="MengR , AsmaroK , MengL , LiuY , MaC , XiC , et al. Upper limb ischemic preconditioning prevents recurrent stroke in intracranial arterial stenosis. Neurology2012;79(18):1853‐61. [PUBMED: PMID: 23035060] ">Meng 2012</a>; <a href="./references#CD012503-bbs2-0004" title="MengR , DingY , AsmaroK , BroganD , MengL , SuiM , et al. Ischemic conditioning is safe and effective for octo‐ and nonagenarians in stroke prevention and treatment. Neurotherapeutics2015;12(3):667‐77. [PUBMED: PMID: 25956401] ">Meng 2015</a>; <a href="./references#CD012503-bbs2-0005" title="MiT , YuF , JiX , SunY , QuD . The interventional effect of remote ischemic preconditioning on cerebral small vessel disease: a pilot randomized clinical trial. European Neurology2016;76(1‐2):28‐34. [PUBMED: PMID: 27351719] ">Mi 2016</a>; <a href="./references#CD012503-bbs2-0006" title="WangY , MengR , SongH , LiuG , HuaY , CuiD , et al. Remote ischemic conditioning may improve outcomes of patients with cerebral small‐vessel disease. Stroke2017;48(11):3064‐72. [PUBMED: PMID: 29042490 ] ">Wang 2017</a>; <a href="./references#CD012503-bbs2-0007" title="ZhaoW , MengR , MaC , HouB , JiaoL , ZhuF , et al. Safety and efficacy of remote ischemic preconditioning in patients with severe carotid artery stenosis before carotid artery stenting: a proof‐of‐concept, randomized controlled trial. Circulation2017;135(14):1325‐35. [PUBMED: PMID: 28174194] ">Zhao 2017</a>). </p> </section> <section id="CD012503-sec-0077"> <h4 class="title">Other potential sources of bias</h4> <p>We judged five trials performed in the same centre in China to be high risk of other bias because these trials had the same principle investigator, who was one of the inventors of the electric autocontrol RIC device used in these studies (<a href="./references#CD012503-bbs2-0003" title="MengR , AsmaroK , MengL , LiuY , MaC , XiC , et al. Upper limb ischemic preconditioning prevents recurrent stroke in intracranial arterial stenosis. Neurology2012;79(18):1853‐61. [PUBMED: PMID: 23035060] ">Meng 2012</a>; <a href="./references#CD012503-bbs2-0004" title="MengR , DingY , AsmaroK , BroganD , MengL , SuiM , et al. Ischemic conditioning is safe and effective for octo‐ and nonagenarians in stroke prevention and treatment. Neurotherapeutics2015;12(3):667‐77. [PUBMED: PMID: 25956401] ">Meng 2015</a>; <a href="./references#CD012503-bbs2-0005" title="MiT , YuF , JiX , SunY , QuD . The interventional effect of remote ischemic preconditioning on cerebral small vessel disease: a pilot randomized clinical trial. European Neurology2016;76(1‐2):28‐34. [PUBMED: PMID: 27351719] ">Mi 2016</a>; <a href="./references#CD012503-bbs2-0006" title="WangY , MengR , SongH , LiuG , HuaY , CuiD , et al. Remote ischemic conditioning may improve outcomes of patients with cerebral small‐vessel disease. Stroke2017;48(11):3064‐72. [PUBMED: PMID: 29042490 ] ">Wang 2017</a>; <a href="./references#CD012503-bbs2-0007" title="ZhaoW , MengR , MaC , HouB , JiaoL , ZhuF , et al. Safety and efficacy of remote ischemic preconditioning in patients with severe carotid artery stenosis before carotid artery stenting: a proof‐of‐concept, randomized controlled trial. Circulation2017;135(14):1325‐35. [PUBMED: PMID: 28174194] ">Zhao 2017</a>). We judged one other study to be at high risk of other bias because two authors were shareholders in the company where the devices used in the study were made (<a href="./references#CD012503-bbs2-0002" title="HougaardKD , HjortN , ZeidlerD , SorensenL , NorgaardA , HansenTM , et al. Remote ischemic perconditioning as an adjunct therapy to thrombolysis in patients with acute ischemic stroke: a randomized trial. Stroke2014;45(159):67. [PUBMED: PMID: 24203849] ">Hougaard 2014</a>). We judged the remaining study to be at low risk of other potential bias as we identified no other bias (<a href="./references#CD012503-bbs2-0001" title="EnglandT , HedstromA , O'SullivanS , DonnellyR , SpriggN , BathP . Remote ischaemic conditioning after stroke trial (RECAST). International Journal of Stroke2016;11 Suppl 4:6. ">England 2016</a>). </p> </section> </section> <section id="CD012503-sec-0078"> <h3 class="title" id="CD012503-sec-0078">Effects of interventions</h3> <p>See: <a href="./full#CD012503-tbl-0001"><b>Summary of findings for the main comparison</b> RIC versus non‐RIC for preventing ischaemic stroke</a>; <a href="./full#CD012503-tbl-0002"><b>Summary of findings 2</b> RIC versus non‐RIC treating ischaemic stroke</a> </p> <p>See: <a href="./full#CD012503-tbl-0001">summary of findings Table for the main comparison</a> and <a href="./full#CD012503-tbl-0002">summary of findings Table 2</a>. </p> <p>Three studies focused on remote ischaemic conditioning (RIC) for preventing ischaemic stroke (<a href="./references#CD012503-bbs2-0003" title="MengR , AsmaroK , MengL , LiuY , MaC , XiC , et al. Upper limb ischemic preconditioning prevents recurrent stroke in intracranial arterial stenosis. Neurology2012;79(18):1853‐61. [PUBMED: PMID: 23035060] ">Meng 2012</a>; <a href="./references#CD012503-bbs2-0004" title="MengR , DingY , AsmaroK , BroganD , MengL , SuiM , et al. Ischemic conditioning is safe and effective for octo‐ and nonagenarians in stroke prevention and treatment. Neurotherapeutics2015;12(3):667‐77. [PUBMED: PMID: 25956401] ">Meng 2015</a>; <a href="./references#CD012503-bbs2-0007" title="ZhaoW , MengR , MaC , HouB , JiaoL , ZhuF , et al. Safety and efficacy of remote ischemic preconditioning in patients with severe carotid artery stenosis before carotid artery stenting: a proof‐of‐concept, randomized controlled trial. Circulation2017;135(14):1325‐35. [PUBMED: PMID: 28174194] ">Zhao 2017</a>), while the other four studies focused on RIC for treating ischaemic stroke (<a href="./references#CD012503-bbs2-0001" title="EnglandT , HedstromA , O'SullivanS , DonnellyR , SpriggN , BathP . Remote ischaemic conditioning after stroke trial (RECAST). International Journal of Stroke2016;11 Suppl 4:6. ">England 2016</a>; <a href="./references#CD012503-bbs2-0002" title="HougaardKD , HjortN , ZeidlerD , SorensenL , NorgaardA , HansenTM , et al. Remote ischemic perconditioning as an adjunct therapy to thrombolysis in patients with acute ischemic stroke: a randomized trial. Stroke2014;45(159):67. [PUBMED: PMID: 24203849] ">Hougaard 2014</a>; <a href="./references#CD012503-bbs2-0005" title="MiT , YuF , JiX , SunY , QuD . The interventional effect of remote ischemic preconditioning on cerebral small vessel disease: a pilot randomized clinical trial. European Neurology2016;76(1‐2):28‐34. [PUBMED: PMID: 27351719] ">Mi 2016</a>; <a href="./references#CD012503-bbs2-0006" title="WangY , MengR , SongH , LiuG , HuaY , CuiD , et al. Remote ischemic conditioning may improve outcomes of patients with cerebral small‐vessel disease. Stroke2017;48(11):3064‐72. [PUBMED: PMID: 29042490 ] ">Wang 2017</a>). The outcomes used in these two categories of studies were different. Therefore, we analysed RIC for preventing and treating ischaemic stroke separately. Although multiple relative risks were used for outcomes analyses, caution should be taken when using these results as the presented data were extracted from only one or two studies with small sample sizes and low quality of evidence. </p> <section id="CD012503-sec-0079"> <h4 class="title">RIC versus non‐RIC for preventing ischaemic stroke</h4> <p>Three studies focused on RIC for preventing ischaemic stroke (<a href="./references#CD012503-bbs2-0004" title="MengR , DingY , AsmaroK , BroganD , MengL , SuiM , et al. Ischemic conditioning is safe and effective for octo‐ and nonagenarians in stroke prevention and treatment. Neurotherapeutics2015;12(3):667‐77. [PUBMED: PMID: 25956401] ">Meng 2015</a>; <a href="./references#CD012503-bbs2-0003" title="MengR , AsmaroK , MengL , LiuY , MaC , XiC , et al. Upper limb ischemic preconditioning prevents recurrent stroke in intracranial arterial stenosis. Neurology2012;79(18):1853‐61. [PUBMED: PMID: 23035060] ">Meng 2012</a>; <a href="./references#CD012503-bbs2-0007" title="ZhaoW , MengR , MaC , HouB , JiaoL , ZhuF , et al. Safety and efficacy of remote ischemic preconditioning in patients with severe carotid artery stenosis before carotid artery stenting: a proof‐of‐concept, randomized controlled trial. Circulation2017;135(14):1325‐35. [PUBMED: PMID: 28174194] ">Zhao 2017</a>). The total number of participants was 371. </p> <section id="CD012503-sec-0080"> <h5 class="title">Primary outcomes</h5> </section> <section id="CD012503-sec-0081"> <h5 class="title">1.1. Ischaemic stroke or recurrent ischaemic stroke at completion of follow‐up</h5> <p>Ischaemic stroke was reported in <a href="./references#CD012503-bbs2-0007" title="ZhaoW , MengR , MaC , HouB , JiaoL , ZhuF , et al. Safety and efficacy of remote ischemic preconditioning in patients with severe carotid artery stenosis before carotid artery stenting: a proof‐of‐concept, randomized controlled trial. Circulation2017;135(14):1325‐35. [PUBMED: PMID: 28174194] ">Zhao 2017</a> and recurrent ischaemic stroke was reported in <a href="./references#CD012503-bbs2-0003" title="MengR , AsmaroK , MengL , LiuY , MaC , XiC , et al. Upper limb ischemic preconditioning prevents recurrent stroke in intracranial arterial stenosis. Neurology2012;79(18):1853‐61. [PUBMED: PMID: 23035060] ">Meng 2012</a> and <a href="./references#CD012503-bbs2-0004" title="MengR , DingY , AsmaroK , BroganD , MengL , SuiM , et al. Ischemic conditioning is safe and effective for octo‐ and nonagenarians in stroke prevention and treatment. Neurotherapeutics2015;12(3):667‐77. [PUBMED: PMID: 25956401] ">Meng 2015</a>. </p> <section id="CD012503-sec-0082"> <h6 class="title">1.1.1 Ischaemic stroke</h6> <p>One study (<a href="./references#CD012503-bbs2-0007" title="ZhaoW , MengR , MaC , HouB , JiaoL , ZhuF , et al. Safety and efficacy of remote ischemic preconditioning in patients with severe carotid artery stenosis before carotid artery stenting: a proof‐of‐concept, randomized controlled trial. Circulation2017;135(14):1325‐35. [PUBMED: PMID: 28174194] ">Zhao 2017</a>), involving 189 participants (50.9% of the total number of participants included in this part of review) presented data on ischaemic stroke. There was no significant difference in the incidence of ischaemic stroke between those allocated to RIC versus those allocated to non‐RIC (risk ratio (RR) 0.22, 95% confidence interval (CI) 0.01 to 4.03; P = 0.31) (<a href="./references#CD012503-fig-0004" title="">Analysis 1.1</a>). </p> </section> <section id="CD012503-sec-0083"> <h6 class="title">1.1.2 Recurrent ischaemic stroke</h6> <p>Two studies (<a href="./references#CD012503-bbs2-0003" title="MengR , AsmaroK , MengL , LiuY , MaC , XiC , et al. Upper limb ischemic preconditioning prevents recurrent stroke in intracranial arterial stenosis. Neurology2012;79(18):1853‐61. [PUBMED: PMID: 23035060] ">Meng 2012</a>; <a href="./references#CD012503-bbs2-0004" title="MengR , DingY , AsmaroK , BroganD , MengL , SuiM , et al. Ischemic conditioning is safe and effective for octo‐ and nonagenarians in stroke prevention and treatment. Neurotherapeutics2015;12(3):667‐77. [PUBMED: PMID: 25956401] ">Meng 2015</a>), involving 182 participants (49.1% of the total number of participants included in this part of review), presented data on recurrent ischaemic stroke. The incidence of recurrent ischaemic stroke was significantly reduced by RIC treatment (RR 0.32, 95% CI 0.12 to 0.83; P = 0.02) (<a href="./references#CD012503-fig-0004" title="">Analysis 1.1</a>). </p> </section> </section> <section id="CD012503-sec-0084"> <h5 class="title">1.2. Death or dependency at completion of follow‐up</h5> <p>Death was not reported in <a href="./references#CD012503-bbs2-0004" title="MengR , DingY , AsmaroK , BroganD , MengL , SuiM , et al. Ischemic conditioning is safe and effective for octo‐ and nonagenarians in stroke prevention and treatment. Neurotherapeutics2015;12(3):667‐77. [PUBMED: PMID: 25956401] ">Meng 2015</a>. The other two studies (<a href="./references#CD012503-bbs2-0003" title="MengR , AsmaroK , MengL , LiuY , MaC , XiC , et al. Upper limb ischemic preconditioning prevents recurrent stroke in intracranial arterial stenosis. Neurology2012;79(18):1853‐61. [PUBMED: PMID: 23035060] ">Meng 2012</a>; <a href="./references#CD012503-bbs2-0007" title="ZhaoW , MengR , MaC , HouB , JiaoL , ZhuF , et al. Safety and efficacy of remote ischemic preconditioning in patients with severe carotid artery stenosis before carotid artery stenting: a proof‐of‐concept, randomized controlled trial. Circulation2017;135(14):1325‐35. [PUBMED: PMID: 28174194] ">Zhao 2017</a>) reported that no participant died during the study period, so analysis was not applicable to the outcome of death. None of the trials (<a href="./references#CD012503-bbs2-0003" title="MengR , AsmaroK , MengL , LiuY , MaC , XiC , et al. Upper limb ischemic preconditioning prevents recurrent stroke in intracranial arterial stenosis. Neurology2012;79(18):1853‐61. [PUBMED: PMID: 23035060] ">Meng 2012</a>; <a href="./references#CD012503-bbs2-0004" title="MengR , DingY , AsmaroK , BroganD , MengL , SuiM , et al. Ischemic conditioning is safe and effective for octo‐ and nonagenarians in stroke prevention and treatment. Neurotherapeutics2015;12(3):667‐77. [PUBMED: PMID: 25956401] ">Meng 2015</a>; <a href="./references#CD012503-bbs2-0007" title="ZhaoW , MengR , MaC , HouB , JiaoL , ZhuF , et al. Safety and efficacy of remote ischemic preconditioning in patients with severe carotid artery stenosis before carotid artery stenting: a proof‐of‐concept, randomized controlled trial. Circulation2017;135(14):1325‐35. [PUBMED: PMID: 28174194] ">Zhao 2017</a>) reported any forms of dependency that enabled us to include them for analysis. </p> </section> <section id="CD012503-sec-0085"> <h5 class="title">Secondary outcomes</h5> </section> <section id="CD012503-sec-0086"> <h5 class="title">1.3. Stroke severity</h5> <p>This outcome was assess by infarct volume in <a href="./references#CD012503-bbs2-0007" title="ZhaoW , MengR , MaC , HouB , JiaoL , ZhuF , et al. Safety and efficacy of remote ischemic preconditioning in patients with severe carotid artery stenosis before carotid artery stenting: a proof‐of‐concept, randomized controlled trial. Circulation2017;135(14):1325‐35. [PUBMED: PMID: 28174194] ">Zhao 2017</a>, which involving 189 participants (50.9% of the total number of participants included in this part of review). Infarct volume was calculated using magnetic resonance imaging (MRI) scans. In participants with multiple lesions, the total infarct volume was added up. The infarct volume was significantly smaller in participant treated with RIC compared with those not treated with RIC (MD ‐0.17 mL, 95% CI ‐0.23 to ‐0.11; P &lt; 0.01; I<sup>2</sup> = 3%) (<a href="./references#CD012503-fig-0006" title="">Analysis 1.3</a>). </p> </section> <section id="CD012503-sec-0087"> <h5 class="title">1.4. Improvement in neurological impairment at completion of follow‐up</h5> <p>None of the three trials reported this outcome in a form that enabled us to include them for this analysis. </p> </section> <section id="CD012503-sec-0088"> <h5 class="title">1.5. Improvement in phycological and cognitive impairment at completion of follow‐up</h5> <p>None of the three trials reported this outcome in a form that enabled us to include them for this analysis. </p> </section> <section id="CD012503-sec-0089"> <h5 class="title">1.6. Cardiovascular events</h5> <p>This outcome was not reported in <a href="./references#CD012503-bbs2-0004" title="MengR , DingY , AsmaroK , BroganD , MengL , SuiM , et al. Ischemic conditioning is safe and effective for octo‐ and nonagenarians in stroke prevention and treatment. Neurotherapeutics2015;12(3):667‐77. [PUBMED: PMID: 25956401] ">Meng 2015</a>. The other two studies (<a href="./references#CD012503-bbs2-0003" title="MengR , AsmaroK , MengL , LiuY , MaC , XiC , et al. Upper limb ischemic preconditioning prevents recurrent stroke in intracranial arterial stenosis. Neurology2012;79(18):1853‐61. [PUBMED: PMID: 23035060] ">Meng 2012</a>; <a href="./references#CD012503-bbs2-0007" title="ZhaoW , MengR , MaC , HouB , JiaoL , ZhuF , et al. Safety and efficacy of remote ischemic preconditioning in patients with severe carotid artery stenosis before carotid artery stenting: a proof‐of‐concept, randomized controlled trial. Circulation2017;135(14):1325‐35. [PUBMED: PMID: 28174194] ">Zhao 2017</a>) reported that no participant experienced cardiovascular events during the study period, so analysis was not applicable to this outcome. </p> </section> <section id="CD012503-sec-0090"> <h5 class="title">1.7. Haemorrhagic stroke</h5> <p>None of the three trials reported this outcome in a form that enabled us to include them for this analysis. </p> </section> <section id="CD012503-sec-0091"> <h5 class="title">1.8. Adverse events associated with RIC treatment</h5> <p>All studies (371 participants: 100% of the total number of participants included in this part of review) reported data on adverse events associated with RIC treatment. One study reported that no participant experienced any adverse events associated with RIC treatment (<a href="./references#CD012503-bbs2-0003" title="MengR , AsmaroK , MengL , LiuY , MaC , XiC , et al. Upper limb ischemic preconditioning prevents recurrent stroke in intracranial arterial stenosis. Neurology2012;79(18):1853‐61. [PUBMED: PMID: 23035060] ">Meng 2012</a>). One study reported that 6/63 participants experienced arm skin petechiae from repeated pressure cuff applications (<a href="./references#CD012503-bbs2-0007" title="ZhaoW , MengR , MaC , HouB , JiaoL , ZhuF , et al. Safety and efficacy of remote ischemic preconditioning in patients with severe carotid artery stenosis before carotid artery stenting: a proof‐of‐concept, randomized controlled trial. Circulation2017;135(14):1325‐35. [PUBMED: PMID: 28174194] ">Zhao 2017</a>), and the other study reported that sporadic petechiae in 3/40 participants were observed (<a href="./references#CD012503-bbs2-0004" title="MengR , DingY , AsmaroK , BroganD , MengL , SuiM , et al. Ischemic conditioning is safe and effective for octo‐ and nonagenarians in stroke prevention and treatment. Neurotherapeutics2015;12(3):667‐77. [PUBMED: PMID: 25956401] ">Meng 2015</a>). The adverse events associated with RIC treatment were significantly higher in participants treated with RIC (RR 10.91; 95% CI 2.01 to 59.28; P = 0.006; I<sup>2</sup> = 0%). No participant experienced severe adverse events associated with RIC treatment. </p> </section> </section> <section id="CD012503-sec-0092"> <h4 class="title">RIC versus non‐RIC for treating ischaemic stroke</h4> <p>Four studies focused on RIC for treating ischaemic stroke (<a href="./references#CD012503-bbs2-0001" title="EnglandT , HedstromA , O'SullivanS , DonnellyR , SpriggN , BathP . Remote ischaemic conditioning after stroke trial (RECAST). International Journal of Stroke2016;11 Suppl 4:6. ">England 2016</a>; <a href="./references#CD012503-bbs2-0002" title="HougaardKD , HjortN , ZeidlerD , SorensenL , NorgaardA , HansenTM , et al. Remote ischemic perconditioning as an adjunct therapy to thrombolysis in patients with acute ischemic stroke: a randomized trial. Stroke2014;45(159):67. [PUBMED: PMID: 24203849] ">Hougaard 2014</a>; <a href="./references#CD012503-bbs2-0005" title="MiT , YuF , JiX , SunY , QuD . The interventional effect of remote ischemic preconditioning on cerebral small vessel disease: a pilot randomized clinical trial. European Neurology2016;76(1‐2):28‐34. [PUBMED: PMID: 27351719] ">Mi 2016</a>; <a href="./references#CD012503-bbs2-0006" title="WangY , MengR , SongH , LiuG , HuaY , CuiD , et al. Remote ischemic conditioning may improve outcomes of patients with cerebral small‐vessel disease. Stroke2017;48(11):3064‐72. [PUBMED: PMID: 29042490 ] ">Wang 2017</a>). The total number of participants was 364. </p> <section id="CD012503-sec-0093"> <h5 class="title">Primary outcomes</h5> </section> <section id="CD012503-sec-0094"> <h5 class="title">2.1. Ischaemic stroke or recurrent ischaemic stroke at completion of follow‐up</h5> <p>None of the four trials reported these outcomes in any forms that enabled us to include them for this analysis. </p> </section> <section id="CD012503-sec-0095"> <h5 class="title">2.2. Death or dependency at completion of follow‐up</h5> <p>Both death and dependency were was reported by one study including 285 participants (78.3% of the total number of participants included in this part of review) (<a href="./references#CD012503-bbs2-0002" title="HougaardKD , HjortN , ZeidlerD , SorensenL , NorgaardA , HansenTM , et al. Remote ischemic perconditioning as an adjunct therapy to thrombolysis in patients with acute ischemic stroke: a randomized trial. Stroke2014;45(159):67. [PUBMED: PMID: 24203849] ">Hougaard 2014</a>). Dependency, assessed by the mean and median of the modified Ranks Scale score and the Barthel Index, was reported in one study (<a href="./references#CD012503-bbs2-0001" title="EnglandT , HedstromA , O'SullivanS , DonnellyR , SpriggN , BathP . Remote ischaemic conditioning after stroke trial (RECAST). International Journal of Stroke2016;11 Suppl 4:6. ">England 2016</a>); we tried to contact the study authors to get the incidence of dependency, but failed to receive any response. Two other studies did not report any of the outcomes (<a href="./references#CD012503-bbs2-0005" title="MiT , YuF , JiX , SunY , QuD . The interventional effect of remote ischemic preconditioning on cerebral small vessel disease: a pilot randomized clinical trial. European Neurology2016;76(1‐2):28‐34. [PUBMED: PMID: 27351719] ">Mi 2016</a>; <a href="./references#CD012503-bbs2-0006" title="WangY , MengR , SongH , LiuG , HuaY , CuiD , et al. Remote ischemic conditioning may improve outcomes of patients with cerebral small‐vessel disease. Stroke2017;48(11):3064‐72. [PUBMED: PMID: 29042490 ] ">Wang 2017</a>). Therefore we only included <a href="./references#CD012503-bbs2-0002" title="HougaardKD , HjortN , ZeidlerD , SorensenL , NorgaardA , HansenTM , et al. Remote ischemic perconditioning as an adjunct therapy to thrombolysis in patients with acute ischemic stroke: a randomized trial. Stroke2014;45(159):67. [PUBMED: PMID: 24203849] ">Hougaard 2014</a> in this analysis. The rate of death or dependency was significantly increased by RIC treatment compared with non‐RIC treatment (RR 2.34; 95% 1.19 to 4.61; P = 0.01) (<a href="./references#CD012503-fig-0009" title="">Analysis 2.2</a>). </p> </section> <section id="CD012503-sec-0096"> <h5 class="title">Secondary outcomes</h5> </section> <section id="CD012503-sec-0097"> <h5 class="title">2.3. Stroke severity</h5> <p>This outcome was assessed by the infarct volume in <a href="./references#CD012503-bbs2-0002" title="HougaardKD , HjortN , ZeidlerD , SorensenL , NorgaardA , HansenTM , et al. Remote ischemic perconditioning as an adjunct therapy to thrombolysis in patients with acute ischemic stroke: a randomized trial. Stroke2014;45(159):67. [PUBMED: PMID: 24203849] ">Hougaard 2014</a> and the NIHSS scores in <a href="./references#CD012503-bbs2-0001" title="EnglandT , HedstromA , O'SullivanS , DonnellyR , SpriggN , BathP . Remote ischaemic conditioning after stroke trial (RECAST). International Journal of Stroke2016;11 Suppl 4:6. ">England 2016</a>. </p> <section id="CD012503-sec-0098"> <h6 class="title">2.3.1. Final infarct volume</h6> <p>This outcome was assessed by the final infarct volume in one study with 149 participants (40.9% of the total number of participants included in this part of review) (<a href="./references#CD012503-bbs2-0002" title="HougaardKD , HjortN , ZeidlerD , SorensenL , NorgaardA , HansenTM , et al. Remote ischemic perconditioning as an adjunct therapy to thrombolysis in patients with acute ischemic stroke: a randomized trial. Stroke2014;45(159):67. [PUBMED: PMID: 24203849] ">Hougaard 2014</a>). No significant difference was detected between participants allocated to RIC treatment and those allocated to non‐RIC treatment (SMD 0.08 mL; 95% CI ‐0.24 to 0.41; P = 0.61) (<a href="./references#CD012503-fig-0010" title="">Analysis 2.3</a>). </p> </section> <section id="CD012503-sec-0099"> <h6 class="title">2.3.2. NIHSS scores</h6> <p>Scores on the NIHSS at three‐month follow‐up were reported in <a href="./references#CD012503-bbs2-0001" title="EnglandT , HedstromA , O'SullivanS , DonnellyR , SpriggN , BathP . Remote ischaemic conditioning after stroke trial (RECAST). International Journal of Stroke2016;11 Suppl 4:6. ">England 2016</a>, which included 26 participants (9.1% of the total number of participants included in this part of review). There was no significant difference between participants allocated to RIC treatment and those allocated to non‐RIC treatment (SMD ‐0.73 points; 95% CI ‐1.53 to 0.07; P = 0.07) (<a href="./references#CD012503-fig-0010" title="">Analysis 2.3</a>). </p> </section> </section> <section id="CD012503-sec-0100"> <h5 class="title">2.4. Improvement in neurological impairment at completion of follow‐up</h5> <p>None of the four trials reported this outcome in a form that enabled us to include them for this analysis. </p> </section> <section id="CD012503-sec-0101"> <h5 class="title">2.5. Improvement in phycological and cognitive impairment at completion of follow‐up</h5> <p>The phycological function was reported in <a href="./references#CD012503-bbs2-0001" title="EnglandT , HedstromA , O'SullivanS , DonnellyR , SpriggN , BathP . Remote ischaemic conditioning after stroke trial (RECAST). International Journal of Stroke2016;11 Suppl 4:6. ">England 2016</a> and the cognitive function was reported in three studies (<a href="./references#CD012503-bbs2-0001" title="EnglandT , HedstromA , O'SullivanS , DonnellyR , SpriggN , BathP . Remote ischaemic conditioning after stroke trial (RECAST). International Journal of Stroke2016;11 Suppl 4:6. ">England 2016</a>; <a href="./references#CD012503-bbs2-0005" title="MiT , YuF , JiX , SunY , QuD . The interventional effect of remote ischemic preconditioning on cerebral small vessel disease: a pilot randomized clinical trial. European Neurology2016;76(1‐2):28‐34. [PUBMED: PMID: 27351719] ">Mi 2016</a>; <a href="./references#CD012503-bbs2-0006" title="WangY , MengR , SongH , LiuG , HuaY , CuiD , et al. Remote ischemic conditioning may improve outcomes of patients with cerebral small‐vessel disease. Stroke2017;48(11):3064‐72. [PUBMED: PMID: 29042490 ] ">Wang 2017</a>). </p> <section id="CD012503-sec-0102"> <h6 class="title">2.5.1 Psychological impairment</h6> <p>Psychological impairment was only reported in <a href="./references#CD012503-bbs2-0001" title="EnglandT , HedstromA , O'SullivanS , DonnellyR , SpriggN , BathP . Remote ischaemic conditioning after stroke trial (RECAST). International Journal of Stroke2016;11 Suppl 4:6. ">England 2016</a>, which included 26 participants (9.1% of the total number of participants included in this part of review). The Zung Depression Score was used for the assessment. There was no significant difference between participants allocated to RIC treatment and those allocated to non‐RIC treatment (SMD ‐0.37 points; 95% CI ‐1.15 to 0.41; P = 0.35) (<a href="./references#CD012503-fig-0011" title="">Analysis 2.5</a>). </p> </section> <section id="CD012503-sec-0103"> <h6 class="title">2.5.2 Cognitive impairment</h6> <p>Three studies reported results of the Mini‐Mental State Examination (MMSE) (<a href="./references#CD012503-bbs2-0001" title="EnglandT , HedstromA , O'SullivanS , DonnellyR , SpriggN , BathP . Remote ischaemic conditioning after stroke trial (RECAST). International Journal of Stroke2016;11 Suppl 4:6. ">England 2016</a>; <a href="./references#CD012503-bbs2-0005" title="MiT , YuF , JiX , SunY , QuD . The interventional effect of remote ischemic preconditioning on cerebral small vessel disease: a pilot randomized clinical trial. European Neurology2016;76(1‐2):28‐34. [PUBMED: PMID: 27351719] ">Mi 2016</a>; <a href="./references#CD012503-bbs2-0006" title="WangY , MengR , SongH , LiuG , HuaY , CuiD , et al. Remote ischemic conditioning may improve outcomes of patients with cerebral small‐vessel disease. Stroke2017;48(11):3064‐72. [PUBMED: PMID: 29042490 ] ">Wang 2017</a>). Seventy‐nine participants (21.7% of the total number of participants included in this part of review) were included in this analysis. There was no significant difference in cognitive function between participants allocated to RIC treatment and those allocated to non‐RIC treatment (SMD ‐0.26 points; 95% CI ‐0.72 to 0.21; P = 0.28) (<a href="./references#CD012503-fig-0011" title="">Analysis 2.5</a>). </p> </section> </section> <section id="CD012503-sec-0104"> <h5 class="title">2.6. Cardiovbascular events</h5> <p>None of the trials reported this outcome in a form that enabled us to include them for this analysis. </p> </section> <section id="CD012503-sec-0105"> <h5 class="title">2.7. Haemorrhagic stroke</h5> <p>None of the trials reported this outcome in a form that enabled us to include them for this analysis. </p> </section> <section id="CD012503-sec-0106"> <h5 class="title">2.8. Adverse events associated with RIC treatment</h5> <p>None of the trials reported this outcome in a form that enabled us to include them for this analysis. </p> </section> </section> <section id="CD012503-sec-0107"> <h4 class="title">Subgroup analyses</h4> <p>Given the limited number of included studies, we did not perform subgroup analyses. If we include more studies in future updates of this review, we will explore differences in the results by creating subgroups according to the number of RIC cycles or their length, position of RIC treatment, and length of treatment. </p> </section> <section id="CD012503-sec-0108"> <h4 class="title">Sensitivity analyses</h4> <p>We did not perform sensitivity analyses because of the limited number of included studies. </p> </section> <section id="CD012503-sec-0109"> <h4 class="title">Funnel plots</h4> <p>We could not use funnel plots because only seven studies were included in this review, and three focused on RIC for preventing ischaemic stroke and the other four focused on RIC for treating ischaemic stroke. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD012503-sec-0110" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD012503-sec-0110"></div> <p>In this Cochrane Review, we have assessed the benefits and harms of remote ischaemic conditioning (RIC) for either preventing or treating ischaemic stroke. </p> <section id="CD012503-sec-0111"> <h3 class="title" id="CD012503-sec-0111">Summary of main results</h3> <section id="CD012503-sec-0112"> <h4 class="title">RIC for preventing ischaemic stroke</h4> <p>Due to the low incidence of death and cardiovascular events in the study population, these analyses were not applicable. Two studies assessed effects of RIC in preventing recurrent ischaemic stroke in participants with symptomatic intracerebral artery stenosis (<a href="./references#CD012503-bbs2-0003" title="MengR , AsmaroK , MengL , LiuY , MaC , XiC , et al. Upper limb ischemic preconditioning prevents recurrent stroke in intracranial arterial stenosis. Neurology2012;79(18):1853‐61. [PUBMED: PMID: 23035060] ">Meng 2012</a>; <a href="./references#CD012503-bbs2-0004" title="MengR , DingY , AsmaroK , BroganD , MengL , SuiM , et al. Ischemic conditioning is safe and effective for octo‐ and nonagenarians in stroke prevention and treatment. Neurotherapeutics2015;12(3):667‐77. [PUBMED: PMID: 25956401] ">Meng 2015</a>), and one study assessed the effects of RIC in preventing ischaemic stroke after carotid stenting in participants with severe carotid stenosis (<a href="./references#CD012503-bbs2-0007" title="ZhaoW , MengR , MaC , HouB , JiaoL , ZhuF , et al. Safety and efficacy of remote ischemic preconditioning in patients with severe carotid artery stenosis before carotid artery stenting: a proof‐of‐concept, randomized controlled trial. Circulation2017;135(14):1325‐35. [PUBMED: PMID: 28174194] ">Zhao 2017</a>). Based on the included studies, we found that RIC might prevent recurrent ischaemic stroke in people with symptomatic intracerebral artery stenosis, and reduce post‐stenting infarct volumes in people undergoing carotid stenting. </p> <p>Two studies reported adverse events associated with repeated RIC treatment, such as sporadic petechiae in local arm skin (<a href="./references#CD012503-bbs2-0004" title="MengR , DingY , AsmaroK , BroganD , MengL , SuiM , et al. Ischemic conditioning is safe and effective for octo‐ and nonagenarians in stroke prevention and treatment. Neurotherapeutics2015;12(3):667‐77. [PUBMED: PMID: 25956401] ">Meng 2015</a>; <a href="./references#CD012503-bbs2-0007" title="ZhaoW , MengR , MaC , HouB , JiaoL , ZhuF , et al. Safety and efficacy of remote ischemic preconditioning in patients with severe carotid artery stenosis before carotid artery stenting: a proof‐of‐concept, randomized controlled trial. Circulation2017;135(14):1325‐35. [PUBMED: PMID: 28174194] ">Zhao 2017</a>). Although the adverse events associated with RIC treatment were significantly higher in participants treated with RIC, no severe adverse events (such as venous thrombosis, arterial dissection, or death) were reported. </p> </section> <section id="CD012503-sec-0113"> <h4 class="title">RIC for treating ischaemic stroke</h4> <p>Two studies assessed the effects of RIC in treating acute ischaemic stroke (<a href="./references#CD012503-bbs2-0002" title="HougaardKD , HjortN , ZeidlerD , SorensenL , NorgaardA , HansenTM , et al. Remote ischemic perconditioning as an adjunct therapy to thrombolysis in patients with acute ischemic stroke: a randomized trial. Stroke2014;45(159):67. [PUBMED: PMID: 24203849] ">Hougaard 2014</a>; <a href="./references#CD012503-bbs2-0001" title="EnglandT , HedstromA , O'SullivanS , DonnellyR , SpriggN , BathP . Remote ischaemic conditioning after stroke trial (RECAST). International Journal of Stroke2016;11 Suppl 4:6. ">England 2016</a>), and another two studies assessed effects of RIC in treating cerebral small vessel disease (<a href="./references#CD012503-bbs2-0005" title="MiT , YuF , JiX , SunY , QuD . The interventional effect of remote ischemic preconditioning on cerebral small vessel disease: a pilot randomized clinical trial. European Neurology2016;76(1‐2):28‐34. [PUBMED: PMID: 27351719] ">Mi 2016</a>; <a href="./references#CD012503-bbs2-0006" title="WangY , MengR , SongH , LiuG , HuaY , CuiD , et al. Remote ischemic conditioning may improve outcomes of patients with cerebral small‐vessel disease. Stroke2017;48(11):3064‐72. [PUBMED: PMID: 29042490 ] ">Wang 2017</a>). Based on the included studies, we found that RIC did not significantly reduce the final infarct volume in people with acute ischaemic stroke who received intravenous thrombolysis, but it might increase the death or dependency of these people. We also found that neurological impairment, assessed by the National Institutes of Health Stroke Scale (NIHSS) score, and psychological impairment were not significantly improved by RIC in this patient population. However, it should be noted that the sample size of one included trial was rather small (n = 26), and the number of participants lost to follow‐up in another included study was rather high. </p> <p>One study compared cognitive function between acute ischaemic stroke participants treated with RIC and non‐RIC (<a href="./references#CD012503-bbs2-0001" title="EnglandT , HedstromA , O'SullivanS , DonnellyR , SpriggN , BathP . Remote ischaemic conditioning after stroke trial (RECAST). International Journal of Stroke2016;11 Suppl 4:6. ">England 2016</a>), while two studies compared cognitive function between cerebral small vessel disease participants treated with RIC and non‐RIC (<a href="./references#CD012503-bbs2-0005" title="MiT , YuF , JiX , SunY , QuD . The interventional effect of remote ischemic preconditioning on cerebral small vessel disease: a pilot randomized clinical trial. European Neurology2016;76(1‐2):28‐34. [PUBMED: PMID: 27351719] ">Mi 2016</a>; <a href="./references#CD012503-bbs2-0006" title="WangY , MengR , SongH , LiuG , HuaY , CuiD , et al. Remote ischemic conditioning may improve outcomes of patients with cerebral small‐vessel disease. Stroke2017;48(11):3064‐72. [PUBMED: PMID: 29042490 ] ">Wang 2017</a>). There was no significant difference in cognitive function between the groups; however, it should be noted that the sample size of the three included trials was rather small (n = 79). </p> </section> </section> <section id="CD012503-sec-0114"> <h3 class="title" id="CD012503-sec-0114">Overall completeness and applicability of evidence</h3> <p>In this review, we widened the protocol inclusion criteria to allow various RIC treatment protocols, and included all trials that recruited people with ischaemic cerebrovascular disease. </p> <p>The three studies focused on preventing ischaemic stroke were carried out in China, and intracerebral artery atherosclerosis was common in this patient population. This may indicate that the results of RIC for preventing ischaemic stroke are likely to be only applicable to the Chinese population, and possibly to Asians, among whom there is a high prevalence of intracerebral artery atherosclerosis. The three included studies tested the same RIC treatment protocol (bilateral arms, five cycles of five minutes' ischaemia/reperfusion, twice daily) with different treatment duration (two weeks, 180 days, and 300 days). We found low‐quality evidence that RIC could prevent recurrent ischaemic stroke in participants with symptomatic intracerebral artery stenosis, and reduce post‐stenting new infarct volumes in participants undergoing carotid stenting. RIC treatment for preventing recurrent ischaemic stroke and ischaemic stroke should be reviewed in light of this evidence. Due to the low incidence of death and cardiovascular diseases, and the relatively small simple sizes of the included studies, the current review found no evidence that RIC could prevent death and cardiovascular diseases in people with ischaemic cerebrovascular disease. The three included studies reported RIC‐specific adverse events, such as sporadic localised petechiae in arm skin, but none of them reported any severe adverse events related to RIC treatment. </p> <p>Four studies focused on RIC for treating ischaemic stroke. One recruited participants with acute ischaemic stroke within 24 hours of symptom onset in the UK (<a href="./references#CD012503-bbs2-0001" title="EnglandT , HedstromA , O'SullivanS , DonnellyR , SpriggN , BathP . Remote ischaemic conditioning after stroke trial (RECAST). International Journal of Stroke2016;11 Suppl 4:6. ">England 2016</a>), one recruited ischaemic stroke candidates considered for intravenous thrombolysis within 4.5 hours in Denmark (<a href="./references#CD012503-bbs2-0002" title="HougaardKD , HjortN , ZeidlerD , SorensenL , NorgaardA , HansenTM , et al. Remote ischemic perconditioning as an adjunct therapy to thrombolysis in patients with acute ischemic stroke: a randomized trial. Stroke2014;45(159):67. [PUBMED: PMID: 24203849] ">Hougaard 2014</a>), one recruited participants with cerebral small vessel disease in China (<a href="./references#CD012503-bbs2-0005" title="MiT , YuF , JiX , SunY , QuD . The interventional effect of remote ischemic preconditioning on cerebral small vessel disease: a pilot randomized clinical trial. European Neurology2016;76(1‐2):28‐34. [PUBMED: PMID: 27351719] ">Mi 2016</a>), and one recruited participants with cerebral small vessel disease‐related mild cognitive impairment in China (<a href="./references#CD012503-bbs2-0006" title="WangY , MengR , SongH , LiuG , HuaY , CuiD , et al. Remote ischemic conditioning may improve outcomes of patients with cerebral small‐vessel disease. Stroke2017;48(11):3064‐72. [PUBMED: PMID: 29042490 ] ">Wang 2017</a>). This may mean that the results of this review are likely to be applicable to people from these countries. The included studies tested two treatment protocols (four cycles of unilateral arm and five cycles of bilateral arms, five minutes' ischaemia/reperfusion), and treatment duration of RIC varied from once to twice daily for 12 consecutive months. We found that RIC may increase death or dependency in people with acute ischaemic stroke who received intravenous thrombolysis, but we did not find any clear evidence that RIC had any effects on the final infarct volume, or psychological impairment in people with acute ischaemic stroke. Neither did we find any influence of RIC on the cognitive impairment in people with acute ischaemic stroke and cerebral small vessel disease. RIC for treating acute ischaemic stroke and cerebral small vessel disease should be reviewed in light of this evidence. Given the poor prognosis of acute ischaemic stroke, especially in those with large artery occlusion, further evidence relating to the use of RIC in this patient population or in combination with endovascular therapy or intravenous thrombolysis would be useful to better clarify the potential benefits and risks in this scenario. </p> </section> <section id="CD012503-sec-0115"> <h3 class="title" id="CD012503-sec-0115">Quality of the evidence</h3> <p>We assessed the quality of the evidence by using the GRADE approach (<a href="./references#CD012503-bbs2-0036" title="GuyattGH , OxmanAD , VistG , KunzR , Falck‐YtterY , Alonso‐CoelloP , et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ2008;336(7650):924‐6. ">Guyatt 2008</a>), and we presented the results in <a href="./full#CD012503-tbl-0001">summary of findings Table for the main comparison</a> and <a href="./full#CD012503-tbl-0002">summary of findings Table 2</a>. </p> <p>Four studies did not specify how allocation concealment was achieved, so we assessed them as having unclear risk of selection bias. Three studies were not blinded for participants, so we assessed them as having high risk of performance bias; and six studies had a high percentage of participants lost to follow‐up, so we assessed them as having high risk of attrition bias. Overall, for each of the outcomes reported in our 'Summary of findings' tables, we graded the quality of evidence as low or very low. </p> <p>From the three studies focused on RIC for preventing ischaemic stroke, there is low‐quality evidence that RIC performed better than non‐RIC in preventing recurrent ischaemic stroke in people with symptomatic intracerebral artery stenosis if treated for several consecutive months, and in reducing incidence of post‐stenting new infarct volume in people undergoing carotid stenting if treated for two consecutive weeks before stenting. However, further research is likely to have a substantial impact on our confidence in the above estimations. </p> <p>Four studies focused on RIC for treating ischaemic stroke. There is low‐quality evidence that RIC might increase death or dependency in acute ischaemic stroke participants treated with intravenous thrombolysis. There is low‐quality evidence that RIC performed no better or no worse than non‐RIC in improving psychological impairment in people with acute ischaemic stroke if started within 24 hours of ictus, and there is low‐quality evidence that RIC performed no better or no worse than non‐RIC in improving cognitive impairment in people with acute ischaemic stroke and cerebral small vessel disease. There is very low quality evidence that RIC performed no better or no worse than non‐RIC in reducing stroke severity (assessed by NIHSS score and infarct volume) in people with acute ischaemic stroke whether or not treated with intravenous thrombolysis. However, further research is likely to have an important impact on our confidence in the above estimations. </p> </section> <section id="CD012503-sec-0116"> <h3 class="title" id="CD012503-sec-0116">Potential biases in the review process</h3> <p>We carried out a comprehensive search across major databases, and we believe that we identified all relevant studies. In addition, we contacted the study authors for additional data when needed. However, as less than 10 trials were included this review and all included studies had a small sample size, potential known and unknown biases cannot be excluded. In addition, this meta‐analysis was slightly hampered by missing data because of studies reporting outcome data as medians and interquartile ranges. We were unable to obtain raw data for these studies, and this may cause biases to our analyses. </p> </section> <section id="CD012503-sec-0117"> <h3 class="title" id="CD012503-sec-0117">Agreements and disagreements with other studies or reviews</h3> <p>The findings of our review regarding RIC for preventing ischaemic stroke are different from other meta‐analyses in the literature. Two Cochrane Reviews (one of which included 29 studies involving 5392 participants who underwent cardiovascular surgery, and the other four studies involving 232 participants who underwent vascular and endovascular surgery) and a non‐Cochrane review (which included 23 studies involving a total of 2200 participants who underwent cardiovascular surgery) analysed the effectiveness of RIC on preventing stroke (<a href="./references#CD012503-bbs2-0033" title="BenstoemC , StoppeC , LiakopoulosOJ , NeyJ , HasencleverD , MeybohmP , et al. Remote ischaemic preconditioning for coronary artery bypass grafting (with or without valve surgery). Cochrane Database of Systematic Reviews2017, Issue 5. [DOI: 10.1002/14651858.CD011719.pub3] ">Benstoem 2017</a>; <a href="./references#CD012503-bbs2-0034" title="DesaiM , GurusamyKS , GhanbariH , HamiltonG , SeifalianAM . Remote ischaemic preconditioning versus no remote ischaemic preconditioning for vascular and endovascular surgical procedures. Cochrane Database of Systematic Reviews2011, Issue 12. [DOI: 10.1002/14651858.CD008472.pub2] ">Desai 2011</a>; <a href="./references#CD012503-bbs2-0039" title="HealyDA , KhanWA , WongCS , MoloneyMC , GracePA , CoffeyJC , et al. Remote preconditioning and major clinical complications following adult cardiovascular surgery: systematic review and meta‐analysis. International Journal of Cardiology2014;176(1):20‐31. ">Healy 2014</a>). These three previous reviews concluded that RIC had no effect on stroke. This discrepancy may be attributable to the different study populations included in different reviews. In this review, we analysed the effects of RIC in preventing ischaemic stroke in people with symptomatic intracerebral artery stenosis or undergoing carotid stenting, and all these participants had a high possibility of recurrent stroke or new brain infarct. However, in people undergoing cardiovascular surgery, vascular surgery and endovascular surgery, the incidence of stroke is relatively very low, and many studies found no participants developing this complication. </p> <p>There has been no previous systematic review of RIC versus non‐RIC in treating ischaemic stroke. The evidence in this review that RIC should not be used routinely in treating ischaemic stroke disagrees with the conclusions of the authors of the four included studies. However, due to the flaws identified in the included studies, further studies on the efficacy of RIC for treating ischaemic stroke are welcomed. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD012503-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012503.pub2/media/CDSR/CD012503/urn:x-wiley:14651858:media:CD012503:CD012503-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012503.pub2/media/CDSR/CD012503/image_t/tCD012503-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD012503-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012503.pub2/media/CDSR/CD012503/image_n/nCD012503-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012503.pub2/full#CD012503-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012503.pub2/media/CDSR/CD012503/image_n/nCD012503-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012503-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012503.pub2/media/CDSR/CD012503/urn:x-wiley:14651858:media:CD012503:CD012503-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012503.pub2/media/CDSR/CD012503/image_t/tCD012503-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD012503-fig-0002" src="/cdsr/doi/10.1002/14651858.CD012503.pub2/media/CDSR/CD012503/image_n/nCD012503-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012503.pub2/full#CD012503-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012503.pub2/media/CDSR/CD012503/image_n/nCD012503-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012503-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012503.pub2/media/CDSR/CD012503/urn:x-wiley:14651858:media:CD012503:CD012503-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012503.pub2/media/CDSR/CD012503/image_t/tCD012503-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD012503-fig-0003" src="/cdsr/doi/10.1002/14651858.CD012503.pub2/media/CDSR/CD012503/image_n/nCD012503-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012503.pub2/full#CD012503-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012503.pub2/media/CDSR/CD012503/image_n/nCD012503-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012503-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012503.pub2/media/CDSR/CD012503/urn:x-wiley:14651858:media:CD012503:CD012503-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012503.pub2/media/CDSR/CD012503/image_t/tCD012503-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 RIC versus non‐RIC for preventing ischaemic stroke, Outcome 1 Ischaemic stroke or recurrent ischaemic stroke at completion of follow‐up." data-id="CD012503-fig-0004" src="/cdsr/doi/10.1002/14651858.CD012503.pub2/media/CDSR/CD012503/image_n/nCD012503-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 RIC versus non‐RIC for preventing ischaemic stroke, Outcome 1 Ischaemic stroke or recurrent ischaemic stroke at completion of follow‐up. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012503.pub2/references#CD012503-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012503.pub2/media/CDSR/CD012503/image_n/nCD012503-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012503-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012503.pub2/media/CDSR/CD012503/urn:x-wiley:14651858:media:CD012503:CD012503-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012503.pub2/media/CDSR/CD012503/image_t/tCD012503-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 RIC versus non‐RIC for preventing ischaemic stroke, Outcome 2 Death or dependency at completion of follow‐up." data-id="CD012503-fig-0005" src="/cdsr/doi/10.1002/14651858.CD012503.pub2/media/CDSR/CD012503/image_n/nCD012503-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 RIC versus non‐RIC for preventing ischaemic stroke, Outcome 2 Death or dependency at completion of follow‐up. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012503.pub2/references#CD012503-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012503.pub2/media/CDSR/CD012503/image_n/nCD012503-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012503-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012503.pub2/media/CDSR/CD012503/urn:x-wiley:14651858:media:CD012503:CD012503-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012503.pub2/media/CDSR/CD012503/image_t/tCD012503-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 RIC versus non‐RIC for preventing ischaemic stroke, Outcome 3 Stroke severity." data-id="CD012503-fig-0006" src="/cdsr/doi/10.1002/14651858.CD012503.pub2/media/CDSR/CD012503/image_n/nCD012503-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 RIC versus non‐RIC for preventing ischaemic stroke, Outcome 3 Stroke severity. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012503.pub2/references#CD012503-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012503.pub2/media/CDSR/CD012503/image_n/nCD012503-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012503-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012503.pub2/media/CDSR/CD012503/urn:x-wiley:14651858:media:CD012503:CD012503-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012503.pub2/media/CDSR/CD012503/image_t/tCD012503-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 RIC versus non‐RIC for preventing ischaemic stroke, Outcome 6 Cardiovascular events." data-id="CD012503-fig-0007" src="/cdsr/doi/10.1002/14651858.CD012503.pub2/media/CDSR/CD012503/image_n/nCD012503-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 RIC versus non‐RIC for preventing ischaemic stroke, Outcome 6 Cardiovascular events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012503.pub2/references#CD012503-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012503.pub2/media/CDSR/CD012503/image_n/nCD012503-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012503-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012503.pub2/media/CDSR/CD012503/urn:x-wiley:14651858:media:CD012503:CD012503-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012503.pub2/media/CDSR/CD012503/image_t/tCD012503-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 RIC versus non‐RIC for preventing ischaemic stroke, Outcome 8 Adverse events associated with RIC treatment." data-id="CD012503-fig-0008" src="/cdsr/doi/10.1002/14651858.CD012503.pub2/media/CDSR/CD012503/image_n/nCD012503-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 RIC versus non‐RIC for preventing ischaemic stroke, Outcome 8 Adverse events associated with RIC treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012503.pub2/references#CD012503-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012503.pub2/media/CDSR/CD012503/image_n/nCD012503-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012503-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012503.pub2/media/CDSR/CD012503/urn:x-wiley:14651858:media:CD012503:CD012503-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012503.pub2/media/CDSR/CD012503/image_t/tCD012503-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 RIC versus non‐RIC treating ischaemic stroke, Outcome 2 Death or dependency at the completion of follow up." data-id="CD012503-fig-0009" src="/cdsr/doi/10.1002/14651858.CD012503.pub2/media/CDSR/CD012503/image_n/nCD012503-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 RIC versus non‐RIC treating ischaemic stroke, Outcome 2 Death or dependency at the completion of follow up. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012503.pub2/references#CD012503-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012503.pub2/media/CDSR/CD012503/image_n/nCD012503-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012503-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012503.pub2/media/CDSR/CD012503/urn:x-wiley:14651858:media:CD012503:CD012503-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012503.pub2/media/CDSR/CD012503/image_t/tCD012503-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 RIC versus non‐RIC treating ischaemic stroke, Outcome 3 Stroke severity." data-id="CD012503-fig-0010" src="/cdsr/doi/10.1002/14651858.CD012503.pub2/media/CDSR/CD012503/image_n/nCD012503-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 RIC versus non‐RIC treating ischaemic stroke, Outcome 3 Stroke severity.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012503.pub2/references#CD012503-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012503.pub2/media/CDSR/CD012503/image_n/nCD012503-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012503-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012503.pub2/media/CDSR/CD012503/urn:x-wiley:14651858:media:CD012503:CD012503-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012503.pub2/media/CDSR/CD012503/image_t/tCD012503-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 RIC versus non‐RIC treating ischaemic stroke, Outcome 5 Improvement in psychological and cognitive impairment at completion of follow‐up." data-id="CD012503-fig-0011" src="/cdsr/doi/10.1002/14651858.CD012503.pub2/media/CDSR/CD012503/image_n/nCD012503-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 RIC versus non‐RIC treating ischaemic stroke, Outcome 5 Improvement in psychological and cognitive impairment at completion of follow‐up. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012503.pub2/references#CD012503-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012503.pub2/media/CDSR/CD012503/image_n/nCD012503-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD012503-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">RIC versus non‐RIC for preventing ischaemic stroke</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>RIC versus non‐RIC for preventing ischaemic stroke</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people at risk for ischaemic stroke<br/> <b>Setting:</b> clinic and inpatient<br/> <b>Intervention:</b> RIC<br/> <b>Comparison:</b> non‐RIC </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with non‐RIC for preventing ischaemic stroke</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with RIC</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Ischaemic stroke or recurrent ischaemic stroke</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Symptomatic intracerebral artery stenosis or carotid stenting</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.31<br/> (0.12 to 0.76) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>371<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>92 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>29 per 1000<br/> (11 to 70) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Death or dependency</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Symptomatic intracerebral artery stenosis or carotid stenting</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>292<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000<br/> (0 to 0) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Improvement in neurological impairment ‐ not reported</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Improvement in psychological and cognitive impairment ‐ not measured</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cardiovascular events ‐ not reported</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Adverse events associated with RIC treatment</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Symptomatic intracerebral artery stenosis or carotid stenting</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 10.91<br/> (2.01 to 59.28) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>371<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000<br/> (0 to 0) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Stroke severity</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 0.17 lower<br/> (0.23 lower to 0.11 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>189<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>4 5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio; <b>RIC:</b> remote ischaemic conditioning; <b>RCT:</b> randomised controlled trial; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgrade by two levels because of very serious risk of bias and serious imprecision. Very serious risk of bias resulted from: participants were not blinded to the treatment protocol in <a href="./references#CD012503-bbs2-0003" title="MengR , AsmaroK , MengL , LiuY , MaC , XiC , et al. Upper limb ischemic preconditioning prevents recurrent stroke in intracranial arterial stenosis. Neurology2012;79(18):1853‐61. [PUBMED: PMID: 23035060] ">Meng 2012</a> and <a href="./references#CD012503-bbs2-0007" title="ZhaoW , MengR , MaC , HouB , JiaoL , ZhuF , et al. Safety and efficacy of remote ischemic preconditioning in patients with severe carotid artery stenosis before carotid artery stenting: a proof‐of‐concept, randomized controlled trial. Circulation2017;135(14):1325‐35. [PUBMED: PMID: 28174194] ">Zhao 2017</a>; <a href="./references#CD012503-bbs2-0003" title="MengR , AsmaroK , MengL , LiuY , MaC , XiC , et al. Upper limb ischemic preconditioning prevents recurrent stroke in intracranial arterial stenosis. Neurology2012;79(18):1853‐61. [PUBMED: PMID: 23035060] ">Meng 2012</a> and <a href="./references#CD012503-bbs2-0004" title="MengR , DingY , AsmaroK , BroganD , MengL , SuiM , et al. Ischemic conditioning is safe and effective for octo‐ and nonagenarians in stroke prevention and treatment. Neurotherapeutics2015;12(3):667‐77. [PUBMED: PMID: 25956401] ">Meng 2015</a> used per‐protocol analysis methods; the corresponding author was one of the inventor of the RIC devices used in the studies; and there was large number of participants lost to follow up during the study period. </p> <p><sup>2</sup> Serious imprecision. Incidence of ischaemic stroke was very lower in <a href="./references#CD012503-bbs2-0007" title="ZhaoW , MengR , MaC , HouB , JiaoL , ZhuF , et al. Safety and efficacy of remote ischemic preconditioning in patients with severe carotid artery stenosis before carotid artery stenting: a proof‐of‐concept, randomized controlled trial. Circulation2017;135(14):1325‐35. [PUBMED: PMID: 28174194] ">Zhao 2017</a>, and the CI for ischaemic stroke was wide. </p> <p><sup>3</sup> Serious imprecision. Incidence of RIC‐associated adverse events were very lower, and the CI for this outcome was very wide. </p> <p><sup>4</sup> Downgrade by two levels because of serious risk of bias and serious indirectness. Very serious risk of bias results from: participants were not blinded to the treatment protocol; the corresponding author was one of the inventor of the RIC devices used; and there was large number of participants lost to follow up during the study period in <a href="./references#CD012503-bbs2-0007" title="ZhaoW , MengR , MaC , HouB , JiaoL , ZhuF , et al. Safety and efficacy of remote ischemic preconditioning in patients with severe carotid artery stenosis before carotid artery stenting: a proof‐of‐concept, randomized controlled trial. Circulation2017;135(14):1325‐35. [PUBMED: PMID: 28174194] ">Zhao 2017</a>. </p> <p><sup>5</sup> Serious indirectness. The infarct volume was used as a surrogate endpoint to assess stroke severity in <a href="./references#CD012503-bbs2-0007" title="ZhaoW , MengR , MaC , HouB , JiaoL , ZhuF , et al. Safety and efficacy of remote ischemic preconditioning in patients with severe carotid artery stenosis before carotid artery stenting: a proof‐of‐concept, randomized controlled trial. Circulation2017;135(14):1325‐35. [PUBMED: PMID: 28174194] ">Zhao 2017</a>. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">RIC versus non‐RIC for preventing ischaemic stroke</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012503.pub2/full#CD012503-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012503-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">RIC versus non‐RIC treating ischaemic stroke</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>RIC versus non‐RIC for treating ischaemic stroke</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with ischaemic stroke<br/> <b>Setting:</b> emergency, clinic and inpatient<br/> <b>Intervention:</b> RIC<br/> <b>Comparison:</b> non‐RIC </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with non‐RIC treating ischaemic stroke</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with RIC</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ischaemic stroke or recurrent ischaemic stroke at completion of follow‐up ‐ not measured</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Death or dependency</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Acute ischaemic stroke treated with intravenous thrombolysis</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 2.34<br/> (1.19 to 4.61) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>285<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>80 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>187 per 1000<br/> (95 to 369) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Improvement in neurological impairment ‐ not measured</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Improvement in psychological and cognitive impairment at completion of follow‐up</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean psychological function was 55.4 points and the mean cognitive function was 27.08 points. </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>SMD 0.29 lower<br/> (0.68 lower to 0.11 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>105<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>3 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cardiovascular events ‐ not reported</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events associated with RIC treatment ‐ not reported</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Stroke severity</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>SMD 0.24 lower<br/> (1.02 lower to 0.54 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>175<br/> (2 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>4 5 6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio; <b>RIC:</b> remote ischaemic conditioning; <b>SMD:</b> standardised mean difference; <b>RCT:</b> randomised controlled trial; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgrade two levels by very serious risk of bias and serious imprecision. High risk of bias resulted from the unclear of allocation concealment, the unblinded treatment protocol to the participants, and large number of participants lost to follow up during the study period in <a href="./references#CD012503-bbs2-0002" title="HougaardKD , HjortN , ZeidlerD , SorensenL , NorgaardA , HansenTM , et al. Remote ischemic perconditioning as an adjunct therapy to thrombolysis in patients with acute ischemic stroke: a randomized trial. Stroke2014;45(159):67. [PUBMED: PMID: 24203849] ">Hougaard 2014</a>. </p> <p><sup>2</sup> Serious imprecision. There was a large number of participants excluded from the study after randomising in <a href="./references#CD012503-bbs2-0002" title="HougaardKD , HjortN , ZeidlerD , SorensenL , NorgaardA , HansenTM , et al. Remote ischemic perconditioning as an adjunct therapy to thrombolysis in patients with acute ischemic stroke: a randomized trial. Stroke2014;45(159):67. [PUBMED: PMID: 24203849] ">Hougaard 2014</a>. </p> <p><sup>3</sup> Downgrade two levels by very serious risk of bias and serious inconsistency. Very serious risk of bias resulted from the unclear of allocation concealment and high risk of other bias in <a href="./references#CD012503-bbs2-0005" title="MiT , YuF , JiX , SunY , QuD . The interventional effect of remote ischemic preconditioning on cerebral small vessel disease: a pilot randomized clinical trial. European Neurology2016;76(1‐2):28‐34. [PUBMED: PMID: 27351719] ">Mi 2016</a> and <a href="./references#CD012503-bbs2-0006" title="WangY , MengR , SongH , LiuG , HuaY , CuiD , et al. Remote ischemic conditioning may improve outcomes of patients with cerebral small‐vessel disease. Stroke2017;48(11):3064‐72. [PUBMED: PMID: 29042490 ] ">Wang 2017</a>, only a small number of participant were included for this outcome, and the corresponding author was one of the inventors of the RIC devices used in <a href="./references#CD012503-bbs2-0005" title="MiT , YuF , JiX , SunY , QuD . The interventional effect of remote ischemic preconditioning on cerebral small vessel disease: a pilot randomized clinical trial. European Neurology2016;76(1‐2):28‐34. [PUBMED: PMID: 27351719] ">Mi 2016</a> and <a href="./references#CD012503-bbs2-0006" title="WangY , MengR , SongH , LiuG , HuaY , CuiD , et al. Remote ischemic conditioning may improve outcomes of patients with cerebral small‐vessel disease. Stroke2017;48(11):3064‐72. [PUBMED: PMID: 29042490 ] ">Wang 2017</a>. </p> <p><sup>4</sup> Serious inconsistency. We detected high level of the heterogeneity for the cognitive impairment. </p> <p><sup>5</sup> Downgrade two levels by very serious risk of bias, serious inconsistency and serious indirectness. High risk of bias resulted from the unclear of allocation concealment, the unblinded treatment protocol to the participants, and large number of participants lost to follow up during the study period in <a href="./references#CD012503-bbs2-0002" title="HougaardKD , HjortN , ZeidlerD , SorensenL , NorgaardA , HansenTM , et al. Remote ischemic perconditioning as an adjunct therapy to thrombolysis in patients with acute ischemic stroke: a randomized trial. Stroke2014;45(159):67. [PUBMED: PMID: 24203849] ">Hougaard 2014</a>; and the small number of participants in <a href="./references#CD012503-bbs2-0001" title="EnglandT , HedstromA , O'SullivanS , DonnellyR , SpriggN , BathP . Remote ischaemic conditioning after stroke trial (RECAST). International Journal of Stroke2016;11 Suppl 4:6. ">England 2016</a>. </p> <p><sup>6</sup> Serious indirectness. The infarct volume was used as a surrogate endpoint to assess stroke severity in <a href="./references#CD012503-bbs2-0002" title="HougaardKD , HjortN , ZeidlerD , SorensenL , NorgaardA , HansenTM , et al. Remote ischemic perconditioning as an adjunct therapy to thrombolysis in patients with acute ischemic stroke: a randomized trial. Stroke2014;45(159):67. [PUBMED: PMID: 24203849] ">Hougaard 2014</a>. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">RIC versus non‐RIC treating ischaemic stroke</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012503.pub2/full#CD012503-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012503-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">RIC versus non‐RIC for preventing ischaemic stroke</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Ischaemic stroke or recurrent ischaemic stroke at completion of follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.31 [0.12, 0.76]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Ischaemic stroke</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>189</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.22 [0.01, 4.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Recurrent ischaemic stroke</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>182</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [0.12, 0.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Death or dependency at completion of follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>292</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Death</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>292</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Dependency</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Stroke severity <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>189</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.17 [‐0.23, ‐0.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 RIC vs sham control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>94</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.15 [‐0.22, ‐0.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 RIC vs blank control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>95</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.21 [‐0.30, ‐0.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4 Improvement in neurological impairment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5 Improvement in psychological and cognitive impairment at completion of follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Cardiovascular events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>292</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 RIC vs sham control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>94</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 RIC vs blank control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>198</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7 Haemorrhagic stroke</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Adverse events associated with RIC treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>10.91 [2.01, 59.28]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 RIC vs sham control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>173</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.78 [1.23, 77.71]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 RIC vs blank control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>198</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>13.58 [0.72, 255.07]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">RIC versus non‐RIC for preventing ischaemic stroke</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012503.pub2/references#CD012503-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012503-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">RIC versus non‐RIC treating ischaemic stroke</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1 Ischaemic stroke or recurrent ischaemic stroke at completion of follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Death or dependency at the completion of follow up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Stroke severity <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>175</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.24 [‐1.02, 0.54]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 NIHSS scores</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.73 [‐1.53, 0.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Infarct volume</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>149</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.08 [‐0.24, 0.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4 Improvement in neurological impairment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Improvement in psychological and cognitive impairment at completion of follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>105</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.29 [‐0.68, 0.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Psychological impairment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.37 [‐1.15, 0.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Cognitive impairment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>79</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.26 [‐0.72, 0.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6 Cardiovascular events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7 Hemorrhagic stroke</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8 Adverse events associated with RIC treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">RIC versus non‐RIC treating ischaemic stroke</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012503.pub2/references#CD012503-tbl-0004">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD012503.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD012503-note-0005">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD012503-note-0003">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD012503-note-0004">Français</a> </li> <li class="section-language"> <a class="" href="ms#CD012503-note-0006">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pt#CD012503-note-0002">Português</a> </li> <li class="section-language"> <a class="" href="ru#CD012503-note-0001">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD012503-note-0012">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012503\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012503\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012503\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012503\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012503\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012503\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012503\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012503\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012503\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012503\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012503\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012503\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012503\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012503\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012503\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012503\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012503\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012503\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=KUoIaN9D&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012503.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012503.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD012503.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD012503.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012503.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740717090537"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012503.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740717090541"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012503.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918daf722f14936e',t:'MTc0MDcxNzA5MC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 